Compound
chondroitin sulfate
Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; dermatan sulfate) is a misnomer and this compound is not a true chondroitin sulfate.
Studied for
5 endpoints · 6 findings · 6 papers
- Radiographic joint-space narrowinglowersEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.
- Serious adverse event incidencelowersEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.
- Tumour necrosis factor alpha concentrationlowersEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.
- WOMAC stiffness subscalelowersEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.
- PTGS2lowersEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.
What the evidence says
How to read these marks6 findings · 5 endpoints · 6 papers · by evidence strength
What moved
6 findings
Decreases serious adverse event incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Chondroitin was associated with statistically significantly lower odds of serious adverse events compared with placebo with Peto odds ratio of 0.40 (95% CI 0.19 to 0.82; n = 6 trials) (level of evidence, moderate).”
Quoted verbatim from Chondroitin for osteoarthritis.. - Study
- meta-analysis
- Population
- adults with osteoarthritis (knee, hip or hand); pooled across 6 trials
Effect 0.4 odds ratio, 95% CI 0.19 to 0.82
Chondroitin for osteoarthritis.2015PMID:25629804Permalink
Decreases radiographic joint-space narrowing
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“These results demonstrate that chondroitin sulfate is effective for reducing the rate of decline in minimum joint space width in patients with OA of the knee.”
Quoted verbatim from The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate .. - Study
- meta-analysis
- Population
- patients with OA of the knee
The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate .2008PMID:18826751Permalink
Decreases radiographic joint-space narrowing
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“These results demonstrate that chondroitin sulfate is effective for reducing the rate of decline in minimum joint space width in patients with knee OA.”
Quoted verbatim from Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration.. - Study
- meta-analysis
- Population
- patients with knee osteoarthritis; updated meta-analysis pooling three placebo-controlled RCTs of 2-year duration
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration.2010PMID:20399895Permalink
Decreases WOMAC stiffness subscale
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Chondroitin sulfate used alone was also found to be effective in reducing WOMAC total score and stiffness score (P=0.038 and P=0.023, respectively).”
Quoted verbatim from Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.. - Study
- RCT
- Duration
- 6 months
- Population
- adults with Kashin-Beck disease (KBD), chondroitin sulfate monotherapy arm, cluster-randomised trial
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.2012PMID:22469850Permalink
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“DIO obese mice treated with CS showed lower serum levels of the mediators of the inflammatory response IL-1β and TNF-α than animals receiving vehicle.”
Quoted verbatim from Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.. - Study
- animal · not in humans
- Duration
- 6 days
- Dose
- 1 g/kg/day
- Population
- Male diet-induced obese mice on a high-fat diet, CS 1 g/kg/day versus saline vehicle for 6 days
Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.2016PMID:26714044Permalink
Inhibits PTGS2
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“CS treatment suppressed rTLR-4 induced the mRNA and protein expression of TLR-4, p-NF-κB, IL-1β, IL-6, COX-2, TNF-α, and MIP-2 in RAW cells.”
Quoted verbatim from The therapeutic potential of chondroitin sulfate in Aspergillus fumigatus keratitis.. - Study
- in vitro · not in humans
- Population
- RAW 264.7 cells (mouse macrophage cell line)
The therapeutic potential of chondroitin sulfate in Aspergillus fumigatus keratitis.2022PMID:35504058Permalink
What it touches on the way
Mechanistic reach
1 entity
1 entities reached.
0 reported hops1 assembled from the scaffold
What the reference databases state
Regulatory determinations
LiverTox likelihood score DLiverTox
LiverTox Likelihood Score D — a possible hepatotoxin, single-to-few case reports. Chapter: "Glucosamine". Source: LiverTox Master List (NBK571102).
The document·Public Domain (NLM/NIH)·Transcribed, not assessed
On the label
Labelled products
915 products
Source: NIH DSLD · Ingredient: chondroitin sulfate · 915 products · Declared amount per serving: 2–1,600 mg (857 products)
914 labels state an amount1 does not
- 1 BodyJoint Support100 mgper 3 Tablet(s)DSLD:257252
- 21st CenturyGlucosamine & Chondroitin plus Hyaluronic Acid + MSM1,200 mgper 1 Tablet(s)DSLD:207477
- 21st CenturyGlucosamine 1500 mg Chondroitin 1200 mg Raspberry Flavored Liquid1,200 mgper 2 Tablespoon(s)DSLD:206527
- 21st CenturyGlucosamine 250 mg Chondroitin 200 mg400 mgper 1 Capsule(s)DSLD:205711
- 21st CenturyGlucosamine 250 mg Chondroitin 200 mg400 mgper 1 Capsule(s)DSLD:205794
- 21st CenturyGlucosamine 250 mg Chondroitin 200 mg400 mgper 1 Capsule(s)DSLD:206611
- 21st CenturyGlucosamine 500 mg Chondroitin 400 mg1,200 mgper 1 Capsule(s)DSLD:205854
- 21st CenturyGlucosamine 500 mg Chondroitin 400 mg1,200 mgper 1 Capsule(s)DSLD:205868
- 21st CenturyGlucosamine 500 mg Chondroitin 400 mg1,200 mgper 1 Tablet(s)DSLD:206007
- 21st CenturyGlucosamine 500 mg Chondroitin 400 mg1,200 mgper 1 Capsule(s)DSLD:206553
- 21st CenturyGlucosamine 500 mg Chondroitin 400 mg1,200 mgper 1 Capsule(s)DSLD:258447
- 21st CenturyGlucosamine 750 mg Chondroitin 600 mg1,200 mgper 2 Tablet(s)DSLD:258448
Show the remaining 903
- 21st CenturyGlucosamine 750 mg Chondroitin 600 mg1,200 mgper 2 Tablet(s)DSLD:304115
- 21st CenturyGlucosamine Chondroitin Advanced plus 1500 mg MSM200 mgper 3 Tablet(s)DSLD:207411
- 21st CenturyMaximum Strength Glucosamine & Chondroitin PlusChondroitin Sulfate Note: 1.2 g1,200 mgper 1 Tablet(s)DSLD:11284
- 21st CenturyMaximum Strength Glucosamine & Chondroitin PlusChondroitin Sulfate Note: 1.2 g1,200 mgper 1 Tablet(s)DSLD:11286
- 365 Everyday ValueGlucosamine Chondroitin & MSM500 mgper 3 Capsule(s)DSLD:207602
- A1 Top World ProductsDoctor's Super Man Power60 mgper 2 Capsule(s)DSLD:25838
- AB American BiologicsUltra ConnexinChondroitin Sulfate Note: 90%50 mgper 4 Capsule(s)DSLD:203695
- AB American BiologicsUltra MSM Forte50 mgper 1 Capsule(s)DSLD:20380
- About TimeJoint500 mgper 3 Vcap(s)(R)DSLD:41316
- Absorb HealthAdvanced Joint Relief170 mgper 2 Capsule(s)DSLD:215710
- Allergy Research GroupFor Women Only266 mgper 3 Capsule(s)DSLD:233170
- Allergy Research GroupFor Women Only266 mgper 3 Capsule(s)DSLD:233171
- Allergy Research GroupMatrixx260 mgper 2 Capsule(s)DSLD:258264
- ALLMAXSkeletocoreBovine42 mgper 1 Tablet(s)DSLD:326019
- ALLMAXVitastack OrangeBovine42 mgper 8.3 Gram(s)DSLD:264245
- Amazing HerbsJointCarePlus100 mgper 2 Tablet(s)DSLD:272869
- Amazon ElementsGlucosamine ComplexBovine Cartilage · Chondroitin Sulfate (Form: from Bovine Cartilage)1,200 mgper 2 Tablet(s)DSLD:203808
- American HealthJoint Support Complex200 mgper 3 Softgel(s)DSLD:16705
- AmvilabGlucosamine and ChondroitinBovine1,200 mgper 3 Tablet(s)DSLD:298147
- AN Amazing Nutrition Amazing FormulasDouble Strength Glucosamine Chondroitin1,200 mgper 2 Tablet(s)DSLD:251889
- AN Amazing Nutrition Amazing FormulasGlucosamine Chondroitin & MSM1,200 mgper 2 Tablet(s)DSLD:251957
- AN Amazing Nutrition Amazing FormulasGlucosamine Chondroitin & MSM600 mgper 2 Tablet(s)DSLD:255948
- AN Amazing Nutrition Amazing FormulasGlucosamine Chondroitin & MSM600 mgper 2 Veggie Capsule(s)DSLD:256001
- AN Amazing Nutrition Amazing FormulasGlucosamine Chondroitin & MSM1,200 mgper 2 Tablet(s)DSLD:314662
- AN Amazing Nutrition Amazing FormulasGlucosamine Chondroitin & MSM600 mgper 2 Capsule(s)DSLD:314663
- Angry SupplementsBedtime Beauty with L-Theanine & Melatoninless than 90% powder200 mgper 2 Capsule(s)DSLD:264378
- Angry SupplementsJoint Support Turmeric + Glucosamine150 mgper 3 Capsule(s)DSLD:264393
- APOPTOSIS NutraceuticalsFlexCell150 mgper 3 Capsule(s)DSLD:323254
- Approved ScienceJointprin +BioPerineChondroitin Sulfate · vegan chondroitin sulfate20 mgper 3 Tablet(s)DSLD:319778
- Arazo NutritionJoint SupportBovine1,200 mgper 3 Tablet(s)DSLD:205202
- Arms Race NutritionElemental450 mgper 4 Capsule(s)DSLD:308114
- aSquared NutritionGlucosamine Chondroitin Turmeric & MSM150 mgper 3 Capsule(s)DSLD:263900
- AvPAKDouble Strength Glucosamine 500mg Chondroitin 400mg1,200 mgper 3 Tablet(s)DSLD:271379
- AvPAKMaximum Strength Glucosamine Chondroitin1,200 mgper 3 Capsule(s)DSLD:271378
- Axe & Sledge SupplementsElbow Grease500 mgper 2 Vcap(s)DSLD:254694
- Back To HealthMSM Glucosamine Chondroitin 1000/1500/1200 mg1,200 mgper 4 Capsule(s)DSLD:174763
- Basic VitaminsGlucosamine 500 mg Chondroitin 400 mg plus MSM1,200 mgper 3 Tablet(s)DSLD:249943
- Basic VitaminsGlucosamine Chondroitin Complex750 mgper 3 Capsule(s)DSLD:250005
- Bernard Jensen'sGlucosamine Chondroitin Plus102 mgper 3 Capsule(s)DSLD:318470
- Best NaturalsGlucosamine + Chondroitin + MSMBovine Cartilage · 1,200 mg1.2 Gram(s)per 3 Capsule(s)DSLD:269644
- Best NaturalsGlucosamine + Chondroitin + MSMBovine Cartilage · 1,200 mg1.2 Gram(s)per 3 Capsule(s)DSLD:273698
- Best NaturalsHyaluronic Acid200 mgper 2 Capsule(s)DSLD:270583
- Best NaturalsHyaluronic Acid200 mgper 2 Capsule(s)DSLD:270584
- Beverly InternationalJoint Care200 mgper 3 Capsule(s)DSLD:332834
- Bio NutritionAdvanced Glucosamine/Chondroitin/MSM500 mgper 3 Tablet(s)DSLD:81411
- BioCareGlucosamine MSM Chondroitin200 mgper 1 Tablet(s)DSLD:309739
- Biotics Research CorporationBio-Cardio 369Bovine300 mgper 1 Packet(s)DSLD:21723
- Biotics Research CorporationBio-Cardio Packs300 mgper 1 Packet(s)DSLD:21749
- Biotics Research CorporationChondro-Plus200 mgper 1 Tablet(s)DSLD:21573
- Biotics Research CorporationChondroSamine PlusBovine500 mgper 3 Capsule(s)DSLD:21565
- Biotics Research CorporationChondroSamine-SBovine500 mgper 3 Capsule(s)DSLD:21568
- Biotics Research CorporationOsteo-B IIBovine · Purified Chondroitin Sulfate (Form: from Bovine)200 mgper 6 Tablet(s)DSLD:22199
- Biotics Research CorporationOsteo-B PlusBovine200 mgper 3 Tablet(s)DSLD:22197
- Biotics Research CorporationOsteo-B PlusBovine200 mgper 3 Tablet(s)DSLD:22198
- Biotics Research CorporationPurified Chondroitin Sulfates250 mgper 1 Tablet(s)DSLD:22520
- BIOVEAChondriotin Sulfate 250 mg250 mgper 1 Capsule(s)DSLD:34412
- BIOVEAChondroitin Sulfate 250 mgBovine250 mgper 1 Vegetarian Capsule(s)DSLD:208036
- BluebonnetGlucosamine Chondroitin & MSM500 mgper 3 Capsule(s)DSLD:332516
- BluebonnetGlucosamine Chondroitin & MSM500 mgper 3 Capsule(s)DSLD:332517
- BluebonnetGlucosamine Chondroitin & MSM500 mgper 3 Capsule(s)DSLD:332518
- BluebonnetGlucosamine Chondroitin Sulfate1,200 mgper 3 Capsule(s)DSLD:314797
- BluebonnetGlucosamine Chondroitin Sulfate1,200 mgper 3 Capsule(s)DSLD:317136
- BluebonnetGSX Formula250 mgper 3 Capsule(s)DSLD:179159
- BluebonnetGSX Formula250 mgper 3 Capsule(s)DSLD:179170
- BluebonnetGSX Formula250 mgper 3 Capsule(s)DSLD:280081
- Bluebonnet Targeted ChoiceJoint Strength200 mgper 2 Capsule(s)DSLD:268549
- Bluebonnet Targeted ChoiceJoint Strength200 mgper 2 Capsule(s)DSLD:279533
- Bluebonnet Targeted ChoiceJoint Support200 mgper 2 Caplet(s)DSLD:180001
- Bluebonnet Targeted ChoiceJoint Support200 mgper 2 Caplet(s)DSLD:180002
- Body Dynamics MaXzorbceuticals NutritionJoint Renewal800 mgper 6 Capsule(s)DSLD:292662
- Bodybuilding.com SignatureGlucosamine & Chondroitin1.2 Gram(s)per 3 Tablet(s)DSLD:207631
- Botanic ChoiceGlucosamine Chondroitin 350 mgBovine100 mgper 1 Capsule(s)DSLD:77922
- Brain ForzaLiquid Glucosamine Chondroitin Melon Berry PomegranateBovine Cartilage1,000 mgper 1 Fluid Ounce(s)DSLD:317974
- Brainchild NutritionalsIntestimend250 mgper 1 Ounce(s)DSLD:328550
- Bricker LabsArthro-Vantage Comprehensive Care400 mgper 2 Capsule(s)DSLD:268034
- Bricker LabsArthro-Vantage Comprehensive Care400 mgper 2 Capsule(s)DSLD:38453
- Bricker LabsETArol Plus Comprehensive Care400 mgper 2 Capsule(s)DSLD:45794
- BronsonChondroitin Sulfate 500 mg500 mgper 1 Capsule(s)DSLD:298861
- BronsonExtra Strength Glucosamine and Chondroitin1,200 mgper 3 Tablet(s)DSLD:257507
- BronsonJoint Complete with Hyaluronic Acid250 mgper 1 Tablet(s)DSLD:298882
- BronsonJoint Complete with Hyaluronic Acid250 mgper 1 Tablet(s)DSLD:298883
- BronsonMSM with Glucosamine, Chondroitin, and BoswellinChondroitin Sulfate Na400 mgper 2 Tablet(s)DSLD:298896
- Bronson LaboratoriesDaily Multi + Joint Support50 mgper 1 Tablet(s)DSLD:257461
- Bronson LaboratoriesEffervescent Glucosamine & Chondroitin1,200 mgper 2 tspDSLD:9136
- Bronson LaboratoriesGlucosamine and ChondroitinBovine100 mgper 1 Capsule(s)DSLD:257495
- Bronson LaboratoriesGlucosamine And Chondroitin100 mgper 1 Capsule(s)DSLD:9138
- Bronson LaboratoriesGlucosamine and Chondroitin Extra Strength1,200 mgper 3 Tablet(s)DSLD:257496
- Bronson LaboratoriesJoint Complete250 mgper 1 Tablet(s)DSLD:9079
- Bronson LaboratoriesJoint Complete250 mgper 1 Tablet(s)DSLD:9081
- Bronson LaboratoriesMSM Complex400 mgper 2 Tablet(s)DSLD:8489
- Built By NatureGlucosamine Chondroitin150 mgper 3 Capsule(s)DSLD:328622
- BulkSupplements.comChondroitin Sulfate750 mgper 750 mgDSLD:312696
- BulkSupplements.comChondroitin Sulfate750 mgper 750 mgDSLD:312697
- BulkSupplements.comChondroitin Sulfate750 mgper 750 mgDSLD:312698
- BulkSupplements.comChondroitin Sulfate750 mgper 750 mgDSLD:312699
- BulkSupplements.comChondroitin Sulfate 1000 mg Capsules1,000 mgper 2 Capsule(s)DSLD:312873
- Buried Treasure Liquid NutrientsJoint Ease + Plus Pomegranate/Raspberry FlavorChondroitin Sulfate Sodium600 mgper 30 mLDSLD:250686
- California Academy of HealthLiquid Advanced Glucosamine Chondroitin Hyaluronic Acid & MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)600 mgper 15 mLDSLD:230761
- California Gold NutritionGlucosamine Chondroitin, MSM plus Hyaluronic AcidBovine600 mgper 2 Veggie Capsule(s)DSLD:273680
- California Gold NutritionGlucosamine, Chondroitin, MSM plus Hyaluronic AcidBovine600 mgper 2 Capsule(s)DSLD:274996
- California Gold NutritionGlucosamine, Chondroitin, MSM plus Hyaluronic AcidBovine600 mgper 2 Capsule(s)DSLD:318835
- California Gold NutritionTotal Veggie Joint200 mgper 2 Capsule(s)DSLD:318845
- CarlsonGlucosamine & Chondroitin1.5 Gram(s)per 3 Tablet(s)DSLD:216195
- CarlsonGlucosamine & Chondroitin1.5 Gram(s)per 3 Tablet(s)DSLD:216202
- CarlsonNutra-Support Joint1,500 mgper 3 Tablet(s)DSLD:209119
- CarlsonNutra-Support Joint1,500 mgper 3 Tablet(s)DSLD:265237
- CarlsonNutra-Support Joint1.5 Gram(s)per 3 Tablet(s)DSLD:309231
- CarlsonNutra-Support Joint1.5 Gram(s)per 3 Tablet(s)DSLD:309933
- CarlsonNutra-Support Joint1.5 Gram(s)per 3 Tablet(s)DSLD:309934
- Chiro-ZymeOSTEO50 mgper 2 Capsule(s)DSLD:176502
- CHK NutritionGlucosamine Complex500 mgper 3 Capsule(s)DSLD:174193
- Clinical ExpertsSpine & Disc250 mgper 7.3 Gram(s)DSLD:279111
- Consumer HealthJointlaxChondroitin Sulfate20 mgper 3 Tablet(s)DSLD:277123
- CoralCoral Joint & Collagen500 mgper 4 Capsule(s)DSLD:43393
- Core NutritionalsFlex800 mgper 8 Tablet(s)DSLD:183122
- Core NutritionalsFLEX800 mgper 8 Tablet(s)DSLD:297981
- Country LifeArthro-Joint & Muscle Support Factors200 mgper 3 Softgel(s)DSLD:181887
- Country LifeBone Density Factors100 mgper 2 Tablet(s)DSLD:75985
- Country LifeBone Density Factors100 mgper 2 Tablet(s)DSLD:75988
- Country LifeGlucosamine Chondroitin Formula1.2 g1,200 mgper 3 Capsule(s)DSLD:326802
- Country LifeGlucosamine Chondroitin FormulaChondroitin Sulfate Sodium Note: 1.2 g1,200 mgper 3 Capsule(s)DSLD:53425
- Country LifeGlucosamine Chondroitin FormulaChondroitin Sulfate Sodium Note: 1.2 g1,200 mgper 3 Capsule(s)DSLD:64872
- CVS HealthDouble Strength Glucosamine ChondroitinChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Caplet(s)DSLD:63031
- CVS HealthDouble Strength Glucosamine Chondroitin With MSMChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Tablet(s)DSLD:66980
- CVS HealthDouble Strength Glucosamine Chondroitin With MSMChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Tablet(s)DSLD:73070
- CVS HealthRegular Strength Glucosamine ChondroitinChondroitin Sulfate Note: 1.21,200 mgper 6 Tablet(s)DSLD:239481
- CVS HealthTriple Strength Glucosamine Chondroitin + D3 1000 IUChondroitin Sulfate Note: 1.2 g1,200 mgper 2 Caplet(s)DSLD:60006
- CVS PharmacyAdvanced Formula Glucosamine Chondroitin Triple Strength With Univestin200 mgper 2 Tablet(s)DSLD:25903
- CVS PharmacyGlucosamine Chondroitin + D3 1000 IU Triple StrengthChondroitin Sulfate Note: 1.2 g1,200 mgper 2 Caplet(s)DSLD:25909
- CVS PharmacyGlucosamine Chondroitin Double StrengthChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Caplet(s)DSLD:64331
- D'Adamo Personalized NutritionDeflect AB100 mgper 2 Capsule(s)DSLD:287132
- DaVinci LaboratoriesNatural Flex400 mgper 1 Capsule(s)DSLD:304020
- DaVinci Laboratories Of VermontGenessentials BH100 mgper 5 Capsule(s)DSLD:22611
- DaVinci Laboratories Of VermontNatural Flex400 mgper 1 Capsule(s)DSLD:23229
- DaVinci Laboratories Of VermontOsteoActiv100 mgper 5 Capsule(s)DSLD:23394
- DCCSA 500Cartilage Extract · from natural cartilage extract500 mgper 1 Capsule(s)DSLD:266775
- DCFlex N' Joint430 mgper 2 Capsule(s)DSLD:245202
- DCFlex N' Joint430 mgper 2 Capsule(s)DSLD:267143
- DCFlex N' Joint430 mgper 2 Capsule(s)DSLD:267144
- DCFlex N' Joint430 mgper 2 Capsule(s)DSLD:267146
- DCFormula 21400 mgper 1 Capsule(s)DSLD:244499
- DCFormula 21400 mgper 1 Capsule(s)DSLD:266083
- DCFormula 21400 mgper 1 Capsule(s)DSLD:267351
- DCFormula 21400 mgper 1 Capsule(s)DSLD:267352
- DCFormula 21400 mgper 1 Capsule(s)DSLD:267353
- DCFormula 21400 mgper 1 Capsule(s)DSLD:267354
- DCFormula 21400 mgper 1 Capsule(s)DSLD:267355
- DCFormula 21400 mgper 1 Capsule(s)DSLD:267356
- DCGCM-1400400 mgper 2 Capsule(s)DSLD:309858
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:245227
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:267088
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:267090
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:267092
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:267093
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:267095
- DCGHC 3X600 mgper 1 Tablet(s)DSLD:267097
- DCGlucosamine Chondroitin & M.S.M.1,200 mgper 3 Tablet(s)DSLD:265821
- DCGlucosamine Chondroitin & M.S.M.1,362 mgper 3 Tablet(s)DSLD:265822
- DCGlucosamine Chondroitin & M.S.M.1,200 mgper 3 Capsule(s)DSLD:309859
- DCJoint Aid w/Omega-3-6-9200 mgper 1 Softgel(s)DSLD:267184
- DCJoint E/S 90048 mgper 1 Capsule(s)DSLD:267157
- DCJoint E/S 90048 mgper 1 Capsule(s)DSLD:267514
- DCJoint E/S 90048 mgper 1 Capsule(s)DSLD:309643
- DCJoint Support200 mgper 2 Capsule(s)DSLD:244655
- DCJoint Support200 mgper 2 Capsule(s)DSLD:265942
- DCJoint Support200 mgper 2 Capsule(s)DSLD:266465
- DCJointGard400 mgper 2 Capsule(s)DSLD:244606
- DCJointGard400 mgper 2 Capsule(s)DSLD:266376
- DCJointGard400 mgper 2 Capsule(s)DSLD:266377
- DCJointGard400 mgper 2 Capsule(s)DSLD:266378
- DCJointGard400 mgper 2 Capsule(s)DSLD:266379
- DCJointGard400 mgper 2 Capsule(s)DSLD:266380
- DCOptiFlex +800 mgper 2 Tablet(s)DSLD:245098
- DCOptiFlex +400 mgper 1 Tablet(s)DSLD:267004
- DCOptiFlex +800 mgper 2 Tablet(s)DSLD:267006
- DCOptiFlex +800 mgper 2 Tablet(s)DSLD:267007
- DCOptiFlex +400 mgper 1 Tablet(s)DSLD:267008
- DCOptiFlex +400 mgper 1 Tablet(s)DSLD:267022
- DCOptiFlex +800 mgper 2 Tablet(s)DSLD:267023
- DCOptiFlex +800 mgper 2 Tablet(s)DSLD:267025
- Dee Cee LaboratoriesFlex N' Joint430 mgper 2 Capsule(s)DSLD:267136
- Dee Cee LaboratoriesFlex N' Joint430 mgper 2 Capsule(s)DSLD:267140
- Dee Cee LaboratoriesFlex N' Joint430 mgper 2 Capsule(s)DSLD:267141
- DG HealthGlucosamine Chondroitin + MSM200 mgper 3 Caplet(s)DSLD:26359
- Doctor's A-ZGlucosamine, Chondroitin & MSM400 mgper 1 Tablet(s)DSLD:2982
- Doctor's BestGlucosamine Chondroitin MSMChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: from Chondroitin Sulfate Sodium)600 mgper 2 Capsule(s)DSLD:24954
- Doctor's BestGlucosamine Chondroitin MSMChondroitin Sulfate Sodium1,200 mgper 4 Capsule(s)DSLD:269285
- Doctor's BestGlucosamine Chondroitin MSM + Hyaluronic AcidChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: from Chondroitin Sulfate Sodium)1,000 mgper 5 Capsule(s)DSLD:269587
- Doctor's BestGlucosamine Chondroitin MSM + Hyaluronic AcidChondroitin Sulfate Sodium1,000 mgper 5 Capsule(s)DSLD:302663
- Doctor's BestGlucosamine Chondroitin MSM + UCIIChondroitin Sulfate Sodium320 mgper 3 Veggie Capsule(s)DSLD:302664
- Doctor's BestGlucosamine Chondroitin MSM with OptiMSMChondroitin Sulfate Sodium1,200 mgper 4 Veggie Capsule(s)DSLD:302665
- Doctor's BestGlucosamine Chondroitin MSM with OptiMSMChondroitin Sulfate Sodium1,200 mgper 4 Capsule(s)DSLD:302666
- Doctor's BestGlucosamine Chondroitin MSM with OptiMSMChondroitin Sulfate Sodium1,200 mgper 4 Veggie Capsule(s)DSLD:302667
- Doctor's BestVegan Glucosamine Chondroitin MSMChondroitin Sulfate600 mgper 4 Veggie Capsule(s)DSLD:302714
- Douglas LaboratoriesChondroitin Sulfate500 mgper 1 Capsule(s)DSLD:10804
- Douglas LaboratoriesChondroitin SulfateChondroitin Sulfate Note: A rich source of Chondroitin Sulfate A and Glucoronic Acid.250 mgper 1 Capsule(s)DSLD:8567
- Douglas LaboratoriesCysto Renew600 mgper 4 Capsule(s)DSLD:232584
- Douglas LaboratoriesGlucosamine Plus200 mgper 1 Vegetarian Capsule(s)DSLD:302509
- Douglas LaboratoriesGlucosamine Plus Extra Strength400 mgper 1 Vegetarian Capsule(s)DSLD:302510
- Douglas LaboratoriesPack #1, Joint Health Pack1,200 mgper 1 Packet(s)DSLD:31413
- Douglas LaboratoriesPack #1, Joint Health Pack1,200 mgper 1 Packet(s)DSLD:31417
- Douglas LaboratoriesUltra-Joint Forte1,200 mgper 3 Tablet(s)DSLD:237106
- Douglas LaboratoriesUltra-Joint Forte1,200 mgper 3 Tablet(s)DSLD:286739
- Dr. BergGlucosamine Chondroitin150 mgper 4 Capsule(s)DSLD:337159
- Dr. Clark StoreGlucosamine & Chondroitin with MSM 995 mg900 mgper 3 Capsule(s)DSLD:215488
- Dr. Stan GubermanUltimate Joint Repair Platinum1,000 mgper 4 Capsule(s)DSLD:33067
- Dr. Theo's OfficialAvosoy CompletePorcine800 mgper 3 Tablet(s)DSLD:276545
- Dr. TobiasHip Knee & Joints1,200 mgper 5 Capsule(s)DSLD:267997
- Dr. TobiasJoint Support1,200 mgper 5 Capsule(s)DSLD:319422
- dr.boGlucosamine Chondroitin Maximum Strength 2100 mg150 mgper 3 Capsule(s)DSLD:328671
- DrFormulasJoint Support Supplement500 mgper 3 Tablet(s)DSLD:224723
- Earthborn ElementsChondroitin Sulfate475 mgper 1 Capsule(s)DSLD:319523
- Ecological FormulasRheumatol Forte100 mgper 1 Capsule(s)DSLD:22908
- Ee Essential elementsGlucosamine Chondroitin300 mgper 1 Capsule(s)DSLD:275162
- EmeraldGlucosamine & Chondroitin + MSM1,000 mgper 4 Capsule(s)DSLD:302605
- EmeraldGlucosamine & Chondroitin + MSM1,000 mgper 4 Capsule(s)DSLD:302606
- Emerald LabsGlucosamine & Chondroitin + MSM1,000 mgper 4 Capsule(s)DSLD:302604
- Emerald LabsGlucosamine & Chondroitin + MSM1,000 mgper 4 Capsule(s)DSLD:302607
- Emergen-CJoint Health TangerineChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium)400 mgper 9.3 Gram(s)DSLD:15880
- EnergyFirstGlucosamine ComplexChondroitin Sulfate Note: 1500 mg1.5 Gram(s)per 3 Tablet(s)DSLD:57734
- EnhancedJoint Blast+Bovine Cartilage50 mgper 3 Capsule(s)DSLD:321432
- Envy NutritionGlucosamine Chondroitin150 mgper 3 Capsule(s)DSLD:241822
- EquipJoint Support150 mgper 3 Capsule(s)DSLD:228393
- Esmond NaturalGlucosamine Chondroitin Complex200 mgper 1 Tablet(s)DSLD:230751
- ETST Earth Science TechJoint Support100 mgper 2 Tablet(s)DSLD:70573
- EvinceNaturalsArthriMend250 mgper 1 Capsule(s)DSLD:229622
- Evlution NutritionFlexMode150 mgper 3 Capsule(s)DSLD:302102
- eXplicit SupplementsGardener's Ease100 mgper 2 Capsule(s)DSLD:287021
- eXplicit SupplementsKnee Free Extra Strength100 mgper 2 Capsule(s)DSLD:310039
- Finest NaturalGlucosamine Chondroitin Double StrengthChondroitin sulfate Note: 90% by USP method1,200 mgper 3 Capsule(s)DSLD:13165
- Finest NutritionGlucosamine Chondroitin1,200 mgper 2 Caplet(s)DSLD:25973
- Finest NutritionGlucosamine ChondroitinChondroitin Sulfate Note: 1.2 g1,200 mgper 2 Caplet(s)DSLD:63968
- Finest NutritionGlucosamine Chondroitinamount not statedper 3 Tablet(s)DSLD:65392
- Finest NutritionGlucosamine Chondroitin MSMChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Caplet(s)DSLD:60540
- Finest NutritionGlucosamine Chondroitin Plus200 mgper 2 Softgel(s)DSLD:26675
- FitLineGelenk-Fit 642 mgper 9 Gram(s)DSLD:321591
- FN Formutech NutritionFlexible Joint Formula600 mgper 4 Capsule(s)DSLD:259067
- ForestLeafGlucosamine Chondroitin450 mgper 3 Capsule(s)DSLD:323037
- FortifyJoint Support100 mgper 2 Tablet(s)DSLD:283917
- Foster RegalGlucosamine 2KCL Chondroitin400 mgper 1 Capsule(s)DSLD:259907
- Foster RegalGlucosamine 2KCL Chondroitin MSM/ILEX400 mgper 2 Capsule(s)DSLD:259935
- Foster RegalGlucosamine 2KCL Chondroitin MSM/ILEX400 mgper 2 Capsule(s)DSLD:261104
- Foster RegalJoint Max Plus430 mgper 2 Capsule(s)DSLD:297001
- Foster RegalJoint Support200 mgper 2 Capsule(s)DSLD:297002
- Foster RegalJointFlex 90048 mgper 1 Capsule(s)DSLD:297000
- Fresh NutritionAdvanced Joint Health90%100 mgper 2 Tablet(s)DSLD:275408
- Fruit AdvantageCherry Prime1,200 mgper 1 Capsule(s)DSLD:276471
- GenacolOptimum500 mgper 15 mLDSLD:257020
- GenacolOptimumBovine500 mgper 3 Tablet(s)DSLD:257026
- Genestra BrandsCDC ForteChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium (Form: from Bovine Cartilage, Bovine Trachea PlantPart: trachea))113 mgper 1 Tablet(s)DSLD:228720
- Genestra BrandsGlucosamine ComplexChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium (Form: from Bovine Cartilage))50 mgper 2 Capsule(s)DSLD:241144
- Genestra BrandsGlucosamine ComplexChondroitin Sulfate Sodium50 mgper 2 Capsule(s)DSLD:306028
- Genestra BrandsTCO ForteChondroitin Sulfate Sodium49 mgper 1 Tablet(s)DSLD:56063
- Geri-CareGlucosamine & Chondroitin400 mgper 1 Capsule(s)DSLD:309686
- GlucoflexGlucosamine & Chondroitin Sulfate1,200 mgper 2 Caplet(s)DSLD:302441
- GlucoflexGlucosamine & Chondroitin Sulfate1,200 mgper 1 Caplet(s)DSLD:46798
- GlucoflexGlucosamine & Chondroitin Sulfate1,200 mgper 2 Caplet(s)DSLD:71089
- GlucoflexGlucosamine & Chondroitin Sulfate (CSA)1,200 mgper 2 Caplet(s)DSLD:180633
- Glucoflex 24Glucosamine & Chondroitin Sulfate Complex1,000 mgper 2 Tablet(s)DSLD:259701
- GNCTamaFlex Complete600 mgper 2 Caplet(s)DSLD:219249
- GNCTriFlex1,200 mgper 3 Caplet(s)DSLD:243611
- GNCTriFlexChondroitin Sulfate Sodium1,200 mgper 3 Caplet(s)DSLD:243614
- GNCTriFlex1,200 mgper 3 Caplet(s)DSLD:243630
- GNCTriFlex Fast-Acting1,200 mgper 2 Caplet(s)DSLD:304425
- GNCTriFlex Fast-ActingChondroitin Sulfate Sodium1,200 mgper 2 Caplet(s)DSLD:304426
- GNCTriFlex Fast-Acting1,200 mgper 4 Yellow Tablet(s)DSLD:44711
- GNCTriFlex Fast-Acting1,200 mgper 2 Caplet(s)DSLD:78621
- GNCTriFlex Liquid Orange1,200 mgper 2 TbspDSLD:76851
- GNCTriFlex Soft Chews Berry Creme400 mgper 1 Soft Chew(s)DSLD:78636
- GNCTriFlex Soft Chews Salted Caramel400 mgper 1 Chew(s)DSLD:174870
- GNCTriFlex SportChondroitin Sulfate Sodium1,200 mgper 4 Caplet(s)DSLD:212516
- GNCTriFlex Sport1,200 mgper 4 Caplet(s)DSLD:841
- GNCTriple Strength Glucosamine Chondroitin 750 mg/600 mgChondroitin Sulfate Sodium600 mgper 1 Caplet(s)DSLD:305838
- GNC Mega MenTriflex1,200 mgper 3 White Tablet(s)DSLD:19428
- GNC Mega MenTriFlex1,200 mgper 3 Caplet(s)DSLD:219869
- GNC Mega MenTriFlex1,200 mgper 3 Caplet(s)DSLD:3559
- GNC SelectJoint Support Complex520 mgper 2 Caplet(s)DSLD:313697
- GNC TriflexGlucosamine Chondroitin MSM1,200 mgper 3 Caplet(s)DSLD:832
- GNC TriflexSport1,200 mgper 4 Caplet(s)DSLD:1653
- GNC TriFlexFast-Acting1,200 mgper 2 Caplet(s)DSLD:243612
- GNC TriFlexFast-Acting1,200 mgper 2 Caplet(s)DSLD:243613
- GNC TriFlexHyaluronic Acid1,200 mgper 3 Tablet(s)DSLD:174842
- GNC TriFlexSAM-e1,200 mgper 3 Capsule(s)DSLD:3203
- GNC TriFlexSoft Chews Berry Creme400 mgper 1 Soft Chew(s)DSLD:243597
- GNC TriFlexSoft Chews ChocolateChondroitin Sulfate Sodium400 mgper 1 Soft Chew(s)DSLD:76849
- GNC TriFlexSoft Chews Peanut ButterChondroitin Sulfate Sodium400 mgper 1 Soft Chew(s)DSLD:76850
- GNC TriFlexSoft Chews Salted Caramel400 mgper 1 Chew(s)DSLD:228785
- GNC TriFlexTriFlexChondroitin Sulfate Sodium1,200 mgper 3 White Tablet(s)DSLD:69623
- GNC Triple StrengthGlucosamine ChondroitinChondroitin Sulfate Sodium600 mgper 1 Caplet(s)DSLD:75040
- GNC Triple StrengthGlucosamine Chondroitin 750 mg/600 mgChondroitin Sulfate Sodium600 mgper 1 Caplet(s)DSLD:224647
- GNC Women's Ultra MegaTriflex1,200 mgper 3 Tablet(s)DSLD:19464
- GNC Women's Ultra MegaTriFlex1,200 mgper 3 Caplet(s)DSLD:5894
- Greens FirstJoint Health FirstBovine Cartilage200 mgper 4 Capsule(s)DSLD:312845
- Greens TodayJoint Formula French Vanilla Flavor500 mgper 15 Gram(s)DSLD:11568
- GSL TechnologyMSM Complex With Gelatin, Glucosamine + Chondroitin2 mgper 1 Tablet(s)DSLD:47595
- GSL TechnologyMSM with Gelatin, Glucosamine & Chondroitin2 mgper 1 Tablet(s)DSLD:317068
- Harvest NaturalsOsteoPoint889 mgper 5 Capsule(s)DSLD:321621
- Health LogicsMythocondrovegetarian Chondroitin Sulfate Sodium600 mgper 1 Capsule(s)DSLD:217293
- Health LogicsRadiate!200 mgper 2 Capsule(s)DSLD:306021
- Health Products DistributorsBone GuardianBovine source30 mgper 6 Tablet(s)DSLD:254891
- Health Thru NutritionGlucosamine Chondroitin400 mgper 1 Tablet(s)DSLD:268125
- Healthy AccentsGlucosamine Chondroitin MSMChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Tablet(s)DSLD:64172
- Healthy ItemsLiposomal Pain-Less250 mgper 1 TbspDSLD:11444
- Healthy Joints SystemGlucosamine & Chondroitin Sulfate1,200 mgper 5 Capsule(s)DSLD:267996
- Herb XtraArthri-DineBovine400 mgper 1 Capsule(s)DSLD:17566
- HerbadietChondroitin Sulfate600 mgper 2 V-Cap(s)DSLD:257472
- HerbadietChondroitin Sulfate600 mgper 2 Capsule(s)DSLD:293616
- HerbadietChondroitin Sulfate Powder1,500 mgper 1500 mgDSLD:293541
- HerbadietGlucosamine with Chondroitin, Turmeric, MSM & Boswellia75 mgper 2 Capsule(s)DSLD:257584
- HerbadietGlucosamine with Chondroitin, Turmeric, MSM & Boswellia75 mgper 2 Capsule(s)DSLD:293689
- HerbadietGlucosamine with Chondroitin, Turmeric, MSM & Boswellia Powder150 mgper 2000 mgDSLD:293750
- HerbaSway LaboratoriesLiquid Glucosamine 1250 mgShark1,200 mgper 5 mLDSLD:3008
- HerbTonicsGlucosamine Chondroitin with Tetrahydrocurcumin150 mgper 3 Vegetarian Capsule(s)DSLD:287048
- Huge NutritionJoint Support1,200 mgper 6 Capsule(s)DSLD:299811
- ImmunotecContralentaChondroitin Sulfate Sodium Note: 90%150 mgper 3 Tablet(s)DSLD:240027
- Indiana Botanic GardensOsteol Joint ComfortBovine250 mgper 2 Capsule(s)DSLD:78069
- Indiana Botanic GardensUltra Glucosamine ChondroitinBovine400 mgper 1 Capsule(s)DSLD:77197
- Indiana Botanic GardensUltra Joint ComplexBovine266.7 mgper 1 Capsule(s)DSLD:46997
- Indiana Botanic GardensUltra Joint ComplexBovine266.7 mgper 1 Capsule(s)DSLD:78323
- InholtraPremium Lubri-Joint600 mgper 3 Liquid Softgel(s)DSLD:44675
- Integrative TherapeuticsGlucosamine Sulfate And Chondroitin 500 mg GS and 400 mg CS1.2 Gram(s)per 3 Tablet(s)DSLD:76949
- Iron Brothers SupplementsJoint Support150 mgper 3 Capsule(s)DSLD:263522
- IronMagLabsFlex RX1,200 mgper 5 Capsule(s)DSLD:47370
- Irwin Naturals3-in-1 Joint Formula1,200 mgper 6 Liquid Softgel(s)DSLD:292060
- Irwin NaturalsTriple-Joint Turmeric Chondroitin Glucosamine100 mgper 3 Liquid Soft-Gel(s)DSLD:256640
- Jarrow FormulasGlucosamine+Chondroitinfrom1,200 mgper 4 Capsule(s)DSLD:307592
- Jarrow FormulasGlucosamine+Chondroitin+MSM1,200 mgper 4 Capsule(s)DSLD:307593
- Jarrow FormulasGlucosamine+Chondroitin+MSMfrom1,200 mgper 4 Capsule(s)DSLD:307594
- JayLab ProAdvanced Joint Support100 mgper 2 Capsule(s)DSLD:288613
- Joint JuiceGlucosamine + Chondroitin Cran Pomegranate200 mgper 8 fl. Oz.DSLD:47870
- Joint JuiceJoint Juice Easy Shot Citrus200 mgper 2.5 TbspDSLD:206118
- Just Ripe NutritionClaritox Pro50 mgper 2 Capsule(s)DSLD:337107
- Just Ripe NutritionQuietum Plus50 mgper 2 Capsule(s)DSLD:337125
- Justified LaboratoriesMaxHeight 5000150 mgper 1 Capsule(s)DSLD:276415
- KALJoint Guard COX-2 ControlBovine100 mgper 2 Tablet(s)DSLD:254656
- Kala HealthMSM Glucosamine ChondroitinChondroitin Sulfate450 mgper 1 Tablet(s)DSLD:311318
- Kala HealthMSM, Glucosamine & Chondroitin PlusChondroitin Sulfate400 mgper 1 Capsule(s)DSLD:311320
- Kala HealthMSM, Glucosamine & Chondroitin VeganChondroitin Sulfate300 mgper 1 Capsule(s)DSLD:311329
- KarunaChondroitin SulfateBovine · from BSE free bovine source400 mgper 1 Capsule(s)DSLD:327084
- Kirkland SignatureExtra Strength Glucosamine 1500 mg Chondroitin 1200 mgBovine · Chondroitin Sulfate Sodium (Form: bovine, porcine) Note: 1200 mg1.2 Gram(s)per 2 Tablet(s)DSLD:207402
- Kirkland SignatureExtra Strength Glucosamine 1500 mg Chondroitin 1200 mg1.2 g1,200 mgper 2 Tablet(s)DSLD:275998
- Kirkland SignatureGlucosamine 1500 mg Chondroitin 1200 mgChondroitin Sulfate Sodium Note: (Bovine) (1200 mg)1.2 Gram(s)per 2 Tablet(s)DSLD:25878
- KrogerGlucosamine Chondroitin & MSMChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Tablet(s)DSLD:62752
- KrogerGlucosamine Chondroitin MSM200 mgper 3 Tablet(s)DSLD:210100
- KrogerJoint Support Glucosamine Chondroitin Plus MSM with Univestin200 mgper 3 Tablet(s)DSLD:12182
- Kukamonga Bienestar y SaludKuka Flex Forte150 mgper 1 Caplet(s)DSLD:305289
- LabradaElastiJoint Fruit PunchBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)1,200 mgper 12.8 Gram(s)DSLD:240213
- LabradaElastiJoint Fruit Punch Flavor1,200 mgper 12.8 Gram(s)DSLD:271756
- LabradaElastiJoint Grape Flavor1,200 mgper 12.8 Gram(s)DSLD:271777
- LabradaElastiJoint OrangeBovine Cartilage1,200 mgper 12.8 Gram(s)DSLD:300239
- Lee Haney's Nutritional Support SystemsAge Management Pack1,200 mgper 9 Capsule(s)DSLD:12985
- LidtkeArthroCare Advanced Extra Strength FormulaBovine · Chondroitin Sulfate (Form: from Bovine)1,350 mgper 4 Capsule(s)DSLD:257176
- Life ExtensionGlucosamine/Chondroitin Capsules450 mgper 1 Capsule(s)DSLD:328467
- Life PriorityTotal Joint ComplexBovine600 mgper 2 Capsule(s)DSLD:334609
- LifeLinkGlucosamine-Chondroitin 1500 mg/1200 mg 9001,200 mgper 3 Capsule(s)DSLD:11829
- LifeSeasons TherapeuticsMobili-TBSE Certified100 mgper 4 Capsule(s)DSLD:310508
- Lifestyle Fitness & NutritionJoint Recovery400 mgper 1 Tablet(s)DSLD:18567
- Liquid HealthExtra Strength Optimum Joint with Glucosamine and Chondroitin Melon Cherry1,000 mgper 1 fl. Oz.DSLD:214597
- Liquid HealthGlucosamine Joint Health Lemon Lime Flavor800 mgper 1 fl. Oz.DSLD:214460
- Live ConsciousMoveWell600 mgper 4 Capsule(s)DSLD:316086
- Logos NutritionalsJoint Marvel150 mgper 3 Tablet(s)DSLD:335714
- Longevity PremierUltra Joint Formula150 mgper 1 Capsule(s)DSLD:277551
- Loomis EnzymesOSTEO72 mgper 2 Capsule(s)DSLD:306298
- Love Me NutritionBody In Motion150 mgper 3 Capsule(s)DSLD:306607
- LuckyVitaminGlucosamine & Chondroitin with MSMBovine Cartilage · 1,200 mg1.2 Gram(s)per 3 Capsule(s)DSLD:283186
- LuckyVitaminGlucosamine & Chondroitin with MSMBovine Cartilage · 1,200 mg1.2 Gram(s)per 3 Veg Capsule(s)DSLD:283187
- Main ProductsUmary USA70 mgper 1 Caplet(s)DSLD:318259
- MajorDouble Strength Glucosamine & Chondroitin1,200 mgper 3 Caplet(s)DSLD:202168
- MajorDouble Strength Glucosamine & Chondroitin1,200 mgper 3 Caplet(s)DSLD:202169
- MajorDouble Strength Glucosamine & Chondroitin1,200 mgper 3 Capsule(s)DSLD:202171
- MajorDouble Strength Glucosamine & Chondroitin1,200 mgper 3 Capsule(s)DSLD:202175
- Martin Avenue PharmacyGlucosamine & Chondroitin Plus With Vitamin C And Bromelain400 mgper 1 Tablet(s)DSLD:19330
- Martin Avenue PharmacyGlucosamine & Chondroitin Plus With Vitamin C And Bromelain400 mgper 1 Tablet(s)DSLD:19338
- Martin Avenue PharmacyJoint Health Support With Glucosamine And MSM100 mgper 3 Tablet(s)DSLD:19577
- Mason NaturalGlucosamine Chondroitin 1500/12001,200 mgper 3 Capsule(s)DSLD:318749
- Mason NaturalGlucosamine Chondroitin 1500/12001,200 mgper 3 Capsule(s)DSLD:321930
- Mason NaturalGlucosamine Chondroitin 1500/12001,200 mgper 3 Capsule(s)DSLD:321931
- Mason NaturalGlucosamine Chondroitin 1500/12001,200 mgper 3 Capsule(s)DSLD:321932
- Mason NaturalGlucosamine Chondroitin 1500/1200 + MSM 10001,200 mgper 3 Tablet(s)DSLD:244908
- Mason NaturalGlucosamine Chondroitin with Vitamin C and Manganese400 mgper 2 Capsule(s)DSLD:207947
- Max Drive NutritionJoint Plus150 mgper 3 Capsule(s)DSLD:215069
- MeijerGlucosamine Chondroitin & MSM1.2 g1,200 mgper 3 Tablet(s)DSLD:271830
- MeijerGlucosamine Chondroitin 1500 mg / 1200 mg1,200 mgper 2 Tablet(s)DSLD:239893
- MeijerGlucosamine Chondroitin 1500/1200 mg1.2 g1,200 mgper 2 Tablet(s)DSLD:271824
- MeijerGlucosamine Chondroitin 1500/1200 mg1.2 g1,200 mgper 2 Tablet(s)DSLD:296506
- MeijerMovement Advanced200 mgper 2 Coated Tablet(s)DSLD:271905
- MeijerUC-II plus Glucosamine & Chondroitin100 mgper 1 Tablet(s)DSLD:296599
- Meijer NaturalsGlucosamine Chondroitin & MSM 1500/750/750Chondroitin Sulfate · Chondroitin Sulfate Complex (Form: standardized to [675 mg] 90% chondroitin sulfate)750 mgper 3 Tablet(s)DSLD:9322
- Meijer NaturalsJoint SupportChondroitin Sulfate · Chondroitin Sulfate Complex (Form: Standardized to [90 mg] 90% Chondroitin Sulfate)100 mgper 3 Tablet(s)DSLD:9349
- Member's MarkGlucosamine 1500 mg Chondroitin 1200 mgChondroitin Sulfate Sodium Note: 1.2 g1,200 mgper 1 Tablet(s)DSLD:46740
- Member's MarkGlucosamine HCl 1500 mg Chondroitin Sulfate Sodium 1200 mg1.2g1,200 mgper 2 Tablet(s)DSLD:321610
- Merry ClinicArthraid67 mgper 2 Capsule(s)DSLD:288615
- Metabolic MaintenanceGlucosamine Chondroitin800 mgper 2 Capsule(s)DSLD:24862
- Metabolic MaintenanceGlucosamine Chondroitin800 mgper 2 Capsule(s)DSLD:274032
- MetagenicsChondroCare400 mgper 2 Tablet(s)DSLD:216013
- MetagenicsChondroCare400 mgper 2 Tablet(s)DSLD:295664
- MetagenicsWellness Essentials Active600 mgper 1 Packet(s)DSLD:216577
- MetagenicsWellness Essentials Active600 mgper 1 Packet(s)DSLD:266551
- MicroTech Professional FormulationsArth-Plus150 mgper 2 Capsule(s)DSLD:214850
- MillecorJoint Support150 mgper 3 Capsule(s)DSLD:261430
- MM Sports NutritionJoint ReliefBovine1.2 Gram(s)per 2 Capsule(s)DSLD:36903
- Moss NutritionArthroSelect250 mgper 4 Capsule(s)DSLD:275495
- Moss NutritionArthroSelect250 mgper 4 Capsule(s)DSLD:329157
- MRM NutritionGlucosamine Chondroitin1,200 mgper 3 Capsule(s)DSLD:261901
- MRM NutritionGlucosamine Chondroitin1,200 mgper 3 Capsule(s)DSLD:305038
- MRM NutritionGlucosamine Chondroitin1,200 mgper 3 Capsule(s)DSLD:319091
- MRM NutritionGlucosamine Chondroitin MSM1,200 mgper 3 Capsule(s)DSLD:261904
- MRM NutritionJoint Synergy +120 mgper 2 Capsule(s)DSLD:319095
- MRM NutritionVegan Glucosamine Chondroitin & Hyaluronic AcidChondroitin Sulfate · Fermented400 mgper 2 Vegan Capsule(s)DSLD:262944
- NatrolFeelAnew334 mgper 2 Tablet(s)DSLD:77897
- NatrolGlucosamine Omega-341.75 mgper 1 Softgel(s)DSLD:202976
- NatrolGlucosamine, Chondroitin & MSM350 mgper 1 Tablet(s)DSLD:332272
- NatrolGlucosamine, Chondroitin & MSM350 mgper 1 Tablet(s)DSLD:332989
- Natural DynamixJoint DX400 mgper 2 Tablet(s)DSLD:55278
- Natural FactorsGlucosamine & Chondroitin 500 mg / 400 mgBovine source1,200 mgper 3 Capsule(s)DSLD:220589
- Natural FactorsGlucosamine & Chondroitin 500 mg / 400 mgBovine source1,200 mgper 3 Capsule(s)DSLD:220597
- Natural FactorsGlucosamine & Chondroitin 500 mg / 400 mgBovine source1,200 mgper 3 Capsule(s)DSLD:220606
- Natural FactorsMSM Joint FormulaBovine source240 mgper 1 Capsule(s)DSLD:220602
- Natural FactorsMSM Joint FormulaBovine source240 mgper 1 Capsule(s)DSLD:282400
- Natural FactorsOsteoMove Extra Strength Joint CareBovine Cartilage · bovine cartilage400 mgper 2 Tablet(s)DSLD:282402
- Natural FactorsOsteoMove Extra Strength Joint CareBovine Cartilage400 mgper 2 Tablet(s)DSLD:282404
- Natural FactorsOsteoMove Extra Strength Joint CareBovine Cartilage400 mgper 2 Tablet(s)DSLD:282405
- Natural NutraRegenerage Collagen Complete150 mgper 3 Capsule(s)DSLD:247084
- Nature MadeTriple Flex Triple Strength800 mgper 2 Caplet(s)DSLD:268025
- Nature MadeTriple Flex Triple Strength800 mgper 2 Caplet(s)DSLD:271076
- Nature MadeTriple Flex with Vitamin D3800 mgper 2 Caplet(s)DSLD:211265
- Nature MadeTripleFlex800 mgper 2 Caplet(s)DSLD:179454
- Nature MadeTripleFlex800 mgper 2 Caplet(s)DSLD:180260
- Nature MadeTripleFlex 50+800 mgper 2 Caplet(s)DSLD:179343
- Nature MadeTripleFlex 50+800 mgper 2 Caplet(s)DSLD:179468
- Nature MadeTripleFlex 50+800 mgper 2 Caplet(s)DSLD:71334
- Nature MadeTripleFlex With Vitamin D3800 mgper 2 Caplet(s)DSLD:179356
- Nature MadeTripleFlex With Vitamin D3800 mgper 2 Caplet(s)DSLD:179359
- Nature Made SolutionsTriple Flex 50+ Triple Strength800 mgper 2 Caplet(s)DSLD:271091
- Nature's AnswerGlucosamine Chondroitin Wtih Tart CherryShark · Chondroitin Sulfate (Form: from Shark)300 mgper 1 TbspDSLD:174838
- Nature's AnswerGlucosamine Chondroitin Wtih Tart CherryShark · Chondroitin Sulfate (Form: from Shark)300 mgper 1 TbspDSLD:174850
- Nature's AnswerLiquid Glucosamine Chondroitin Great Tasting OrangeBovine300 mgper 1 TbspDSLD:264041
- Nature's AnswerLiquid Glucosamine Chondroitin Orange FlavoredBovine300 mgper 1 TbspDSLD:188848
- Nature's BlendGlucosamine Chondroitin Complex200 mgper 1 Tablet(s)DSLD:274642
- Nature's BlendGlucosamine Chondroitin Complex200 mgper 1 Tablet(s)DSLD:274667
- Nature's BlendGlucosamine Chondroitin MSM1,000 mgper 3 Caplet(s)DSLD:310399
- Nature's BlendMaximum Strength Glucosamine Chondroitin1,200 mgper 3 Capsule(s)DSLD:310406
- Nature's BountyExtra Strength Glucosamine Chondroitin ComplexChondroitin Sulfate Note: 1.2 g1,200 mgper 1 Softgel(s)DSLD:17352
- Nature's BountyExtra Strength Glucosamine Chondroitin ComplexChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Softgel(s)DSLD:29223
- Nature's BountyFlex-A-MinChondroitin Sulfate Note: 1.2g1,200 mgper 3 Tablet(s)DSLD:67559
- Nature's HarmonyChewable Glucosamine And Chondroitin With MSM125 mgper 1 Tablet(s)DSLD:21862
- Nature's HarmonyGlucosamine + Chondroitin Sulfates ComplexChondroitin sulfate sodium Note: bovine200 mgper 2 Tablet(s)DSLD:22036
- Nature's NutritionGlucosamine Chondroitin150 mgper 3 Veggie Capsule(s)DSLD:279100
- Nature's SecretInholtra Premium Lubri-Joint420 mgper 3 Liquid Softgel(s)DSLD:277733
- Nature's SunshineChondroitin600 mgper 2 Capsule(s)DSLD:278059
- Nature's WayGS-500 & Chondroitin1.2 Gram(s)per 1 Tablet(s)DSLD:205146
- Nature's WayJoint Movement Glucosamine Extra Strength Berry Flavored1,200 mgper 30 mLDSLD:259459
- Nature's WayJoint Movement Glucosamine Ultra Strength Berry Flavored1,200 mgper 1 Fluid Ounce(s)DSLD:327986
- Nature's WayJoint Movement Glucosamine Ultra Strength Berry Flavored1,200 mgper 30 mLDSLD:328131
- Nature's Way FlexMaxGlucosamine Chondroitin600 mgper 2 Tablet(s)DSLD:201498
- Nature's Way FlexMaxGlucosamine Chondroitin600 mgper 2 Tablet(s)DSLD:201568
- Nature's Way FlexMaxGlucosamine Chondroitin600 mgper 2 Tablet(s)DSLD:201570
- NATURELO Premium SupplementsGlucosamine Chondroitin & MSM1,200 mgper 2 Capsule(s)DSLD:296657
- Natures PlusConnect-All50 mgper 2 Tablet(s)DSLD:228309
- NaturesPlusAdvanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx-JointBovine800 mgper 3 Extended Delivery Tablet(s)DSLD:298221
- NaturesPlusAdvanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx-JointBovine800 mgper 3 Extended Delivery Tablet(s)DSLD:298222
- NaturesPlusAdvanced Therapeutics Glucosamine Chondroitin MSM with Collagen Ultra Rx-Joint Delicious Mixed Berry FlavoredChondroitin Sulfate800 mgper 29.57 mLDSLD:298223
- NaturesPlusAdvanced Therapeutics Glucosamine Chondroitin Rx-JointGlucuronic1,000 mgper 2 Extended Delivery Tablet(s)DSLD:298224
- NaturesPlus Advanced TherapeuticsAdvanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx-Joint Triple StrengthBovine1,600 mgper 4 Extended Delivery Tablet(s)DSLD:319137
- NaturesPlus Advanced TherapeuticsGlucosamine Chondroitin MSM with Collagen Ultra Rx-Joint Liquid Honey Lemon Flavor800 mgper 29.57 mLDSLD:319138
- NaturesPlus AgeLossJoint SupportChondroitin Sulfate300 mgper 3 Tablet(s)DSLD:251039
- New SunGlucosamine & Chondroitin With Trace MineralsBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)600 mgper 2 Capsule(s)DSLD:12348
- New SunGlucosamine & Chondroitin With Trace MineralsBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)600 mgper 2 Capsule(s)DSLD:12349
- New SunGlucosamine Sulfate Complex220 mgper 2 Capsule(s)DSLD:12347
- NewtonEverettRelevia 31,200 mgper 2 Tablet(s)DSLD:82630
- NewtonEverettRelevia 41,200 mgper 2 Tablet(s)DSLD:82636
- NewtonEverettRelevia 61,200 mgper 2 Tablet(s)DSLD:82642
- NewtonEverettSuperFlex-3 Advanced720 mgper 1 Packet(s)DSLD:213177
- NewtonEverettSuperFlex-3 Effervescent Drink Mix Tangerine Flavor1,200 mgper 12.85 Gram(s)DSLD:66724
- NewtonEverettSuperFlex-3 Triple Strength1,200 mgper 2 Tablet(s)DSLD:213120
- NewtonEverettSuperFlex-4 with Vitamin D1,200 mgper 2 Tablet(s)DSLD:213291
- NewtonEverettSuperFlex-61,200 mgper 2 Tablet(s)DSLD:218120
- NewtonEverettSuperFlex-PM1,200 mgper 2 Tablet(s)DSLD:213337
- NikkenOsteoDenxChicken · Chondroitin sulfate (Form: from chicken)100 mgper 1 Capsule(s)DSLD:11291
- NMx Wellness InnovationsCosamin ASU350 mgper 3 Capsule(s)DSLD:173737
- NMx Wellness InnovationsCosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture350 mgper 3 Capsule(s)DSLD:228878
- NMx Wellness InnovationsCosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture350 mgper 3 Capsule(s)DSLD:228882
- NMx Wellness InnovationsCosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture350 mgper 3 Capsule(s)DSLD:228918
- NMx Wellness InnovationsCosamin ASU Advanced FormulaSodium Chondroitin Sulfate Note: Contains approximately 8% moisture350 mgper 3 Capsule(s)DSLD:205155
- NMx Wellness InnovationsCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Capsule(s)DSLD:228832
- NMx Wellness InnovationsCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Capsule(s)DSLD:228850
- NMx Wellness InnovationsCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Capsule(s)DSLD:228855
- NMx Wellness InnovationsCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Capsule(s)DSLD:228861
- NMx Wellness InnovationsCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Capsule(s)DSLD:228913
- NMX Wellness InnovationsCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Caplet(s)DSLD:228899
- Nora RossHealthy Joints +80 mgper 1 Capsule(s)DSLD:319544
- Nova NutritionsGlucosamine Chondroitin MSMBovine Cartilage · Chondroitin Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 1 Capsule(s)DSLD:229306
- Nova NutritionsHyaluronic Acid with Glucosamine & Chondroitin200 mgper 2 Capsule(s)DSLD:229318
- NOWChondroitin Sulfate 600 mgBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 gper 2 Capsule(s)DSLD:14700
- NOWChondroitin Sulfate 600 mgBovine Cartilage · BSE-free, 1,200 mg1.2 Gram(s)per 2 Capsule(s)DSLD:313811
- NOWExtra Strength Glucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 gper 2 Tablet(s)DSLD:13133
- NOWExtra Strength Glucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 2 Tablet(s)DSLD:57306
- NOWExtra Strength Glucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 2 Tablet(s)DSLD:57307
- NOWExtra Strength Glucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 2 Tablet(s)DSLD:57308
- NOWGlucosamine & ChondroitinBovine Cartilage600 mgper 2 Veg Capsule(s)DSLD:314355
- NOWGlucosamine & ChondroitinBovine Cartilage600 mgper 2 Veg Capsule(s)DSLD:314356
- NOWGlucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)600 mgper 2 Capsule(s)DSLD:55758
- NOWGlucosamine & Chondroitin Plus MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 gper 3 Capsule(s)DSLD:13121
- NOWGlucosamine & Chondroitin with MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 3 Veg Capsule(s)DSLD:245794
- NOWGlucosamine & Chondroitin With MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 3 Veg Capsule(s)DSLD:245796
- NOWGlucosamine & MSMBovine Cartilage50 mgper 2 Capsule(s)DSLD:335241
- NOWGlucosamine & MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)50 mgper 2 Veg Capsule(s)DSLD:57313
- NOWGlucosamine & MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)50 mgper 2 Veg Capsule(s)DSLD:74489
- NOWGlucosamine & MSM High PotencyBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)50 mgper 2 Capsule(s)DSLD:13136
- NOWLiquid Glucosamine & Chondroitin with MSMBovine Cartilage600 mgper 15 mLDSLD:335266
- NOWLiquid Glucosamine & Chondroitin With MSMBovine Cartilage600 mgper 15 mLDSLD:314424
- NOWSustained Release Glucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 3 Tablet(s)DSLD:14328
- NOWSustained Release Glucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 gper 3 Tablet(s)DSLD:14330
- Number One NutritionGlucosamine Chondroitin + MSM 150 mgper 3 Capsule(s)DSLD:335976
- NuMedicaJoint Replete500 mgper 4 Capsule(s)DSLD:323550
- Nutra BioGenesisArthroGenxChondroitin Sulfate Sodium250 mgper 5 Capsule(s)DSLD:322977
- Nutra SportJoint MaintenanceBeef Cartilage extract400 mgper 1 Tablet(s)DSLD:319221
- Nutra SportJoint Max300 mgper 1 Tablet(s)DSLD:319222
- Nutra SportJoint Support TabletsChondroitin Sulfate · Chondroitin Sulfate Complex (Form: Standardized to [90 mg] 90% Chondroitin Sulfate)100 mgper 3 Tablet(s)DSLD:249472
- NutraBioChondroitin Sulfate1,500 mgper 1.5 Gram(s)DSLD:51020
- NutraBioChondroitin Sulfate 1500 Milligrams1,500 mgper 2 Capsule(s)DSLD:51047
- NutraBioExtreme Joint CareChondroitin Sulfate Note: (USP) (low molecular weight) (sodium salt)500 mgper 4 Capsule(s)DSLD:248323
- NutraBioGlucosamine Chondroitin & MSMChondroitin Sulfate Note: low molecular weight1,000 mgper 4 Capsule(s)DSLD:248308
- NutraBioGlucosamine Chondroitin & MSMlow molecular weight1,000 mgper 4 Capsule(s)DSLD:318075
- NutraBioGlucosamine, Chondroitin & MSMChondroitin Sulfate Note: low molecular weight1,200 mgper 4 Capsule(s)DSLD:51518
- NutraBio PerformanceExtreme Joint Carelow molecular weight500 mgper 4 Capsule(s)DSLD:322547
- NutracraftJointPlex150 mgper 3 Capsule(s)DSLD:246490
- NutraKeyInnoflex Ultra Strength Lemon Lime1,200 mgper 12.7 Gram(s)DSLD:287376
- NutraKey Health Performance Glucosamine Chondroitin MSM1,000 mgper 4 Capsule(s)DSLD:287404
- Nutramax Laboratories Consumer CareCosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture350 mgper 3 Capsule(s)DSLD:228872
- Nutramax Laboratories Consumer CareCosamin ASU350 mgper 3 Capsule(s)DSLD:240455
- Nutramax Laboratories Consumer CareCosamin DSSodium Chondroitin Sulfate Note: (Contains approximately 8% moisture) (1200 mg)1.2 Gram(s)per 3 Capsule(s)DSLD:228862
- Nutramax Laboratories Consumer CareCosamin DS1.2 Gram(s)per 3 Capsule(s)DSLD:55028
- Nutramax Laboratories Consumer CareMaximum Strength Cosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture800 mgper 4 Capsule(s)DSLD:54976
- Nutramax Laboratories Consumer CareMaximum Strength Cosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture800 mgper 4 Capsule(s)DSLD:54980
- Nutramax Laboratories Consumer CareMaximum Strength Cosamin ASUSodium Chondroitin Sulfate Note: Contains approximately 8% moisture800 mgper 4 Capsule(s)DSLD:54983
- NutriCologyBone Calcium Complex266 mgper 3 Capsule(s)DSLD:234806
- NutriCologyBone Calcium Complex266 mgper 3 Capsule(s)DSLD:234807
- NutriCologyConnection260 mgper 2 Capsule(s)DSLD:235510
- NutriCologyConnection260 mgper 2 Capsule(s)DSLD:258533
- NutricostGlucosamine with Chondroitin & MSM90 mgper 2 Tablet(s)DSLD:270417
- NutriFlairGlucosamine Chondroitin Turmeric & MSM150 mgper 3 Vegetable Capsule(s)DSLD:268822
- NutriFlairGlucosamine Chondroitin Turmeric & MSM 2100 mg150 mgper 3 Capsule(s)DSLD:299689
- NutriRiseGlucosamine Chondroitin150 mgper 3 Veggie Capsule(s)DSLD:257158
- NutriSuppzUltra Joint Flex150 mgper 3 Veggie Capsule(s)DSLD:268914
- Nutrition53Relief1 Joint Health FormulaBovine · USP, 90%600 mgper 1 Capsule(s)DSLD:271957
- NutritionworksGlucosamine & Chondroitin Sulfate (CSA)1,200 mgper 6 Caplet(s)DSLD:32380
- OL Olympian LabsChondroytamine HCL400 mgper 2 Capsule(s)DSLD:9461
- OL Olympian LabsGlu-Chon-MSM800 mgper 3 Tablet(s)DSLD:9577
- OL Olympian LabsGlucomax800 mgper 2 Tablet(s)DSLD:67109
- OL Olympian LabsPlatinum Turmeric with BioPerine50 mgper 2 Capsule(s)DSLD:259850
- OL Olympian LabsX7 - Care200 mgper 2 Tablet(s)DSLD:176024
- OmneDiemConnective Tissue TLC Unflavored800 mgper 6.4 Gram(s)DSLD:334385
- OmneDiemPure Norwegian Bone Broth Natural Chicken Taste90 mgper 12 Gram(s)DSLD:320680
- ON Optimum NutritionGlucosamine + CSA Super Strength1.2 Gram(s)per 2 Tablet(s)DSLD:57509
- On The Go! Joint JuiceGlucosamine - Chondroitin Drink Mix Blueberry Acai200 mgper 1 Packet(s)DSLD:26235
- OneBodeFlex280 mgper 1 Capsule(s)DSLD:12751
- Optimal AlphaAlpha Joint Support960 mgper 4 Capsule(s)DSLD:256160
- Optimum Health NutritionJoint Boost Lemon-Lime800 mgper 1 Ounce(s)DSLD:240298
- Orphic NutritionGlucosamine Chondroitin150 mgper 3 Capsule(s)DSLD:285527
- Ortho Molecular ProductsChondro-Flx267 mgper 1 Capsule(s)DSLD:174417
- Ortho Molecular ProductsChondro-Flx300 mgper 1 Capsule(s)DSLD:275383
- OrzaxGlucosamine Chondroitin MSM Complex300 mgper 3 Tablet(s)DSLD:310489
- OSN LabsKryp2Lean1,200 mgper 4 Capsule(s)DSLD:273923
- Osteo Bi-FlexOsteo Bi-Flex Regular StrengthChondroitin Sulfate Note: 1.2 g1,200 mgper 6 Caplet(s)DSLD:11065
- Osteo Bi-FlexOsteo Bi-Flex Regular StrengthChondroitin Sulfate Note: 1.2 g1,200 mgper 6 Caplet(s)DSLD:26050
- OsumexGMC2 for Humans200 mgper 10 mLDSLD:255218
- OweliMove150 mgper 3 Capsule(s)DSLD:314845
- Parrillo PerformanceJoint Formula100 mgper 2 Tablet(s)DSLD:322529
- Pathway To HealingJoint Support95 mgper 2 Capsule(s)DSLD:14977
- Performance InspiredJoint Support Plus150 mgper 2 Tablet(s)DSLD:272234
- PerqueJoint GuardChondroitin Sulfate Note: active, soluble225 mgper 3 Capsule(s)DSLD:240765
- PerqueJoint GuardChondroitin Sulfate Note: active, soluble225 mgper 3 Capsule(s)DSLD:240767
- PharmaxChondriotinChondroitin Sulfate Sodium600 mgper 1 Tablet(s)DSLD:56156
- Pharmaxa LabsFlexoPlexChondroitin Sulfate Sodium Salt600 mgper 2 Tablet(s)DSLD:321343
- Power Blendz NutritionJoint Support1,200 mgper 5 Capsule(s)DSLD:263694
- Power Blendz NutritionJoint Support Complete1,200 mgper 5 Capsule(s)DSLD:318658
- Premium CertifiedJointsylChondroitin Sulfate20 mgper 3 Tablet(s)DSLD:248669
- Primal PharmPROTECT150 mgper 3 Capsule(s)DSLD:276406
- Prince Of PeaceUltra Strength Joint Health578.4 mgper 10 ccDSLD:58810
- Princess LifestyleArthrolyn67 mgper 2 Capsule(s)DSLD:240436
- Priority One Nutritional SupplementsCardio PlusChondroitin Sulfate Note: 90%54 mgper 3 Capsule(s)DSLD:277349
- Priority One Nutritional SupplementsCardio Plus54 mgper 3 Capsule(s)DSLD:277350
- Priority One Nutritional SupplementsJoint Flex90%600 mgper 2 Capsule(s)DSLD:277377
- ProCapsComplete Joint EffortCalcium Chondroitin Sulfate1,200 mgper 1 Packet(s)DSLD:331536
- ProCapsMaximum Joint EffortCalcium Chondroitin Sulfate1,200 mgper 1 Packet(s)DSLD:331577
- ProCaps LaboratoriesChondroitin Sulfate 1200Calcium Chondroitin Sulfate · Chondroitin Sulfate (Form: from Calcium Chondroitin Sulfate)1,200 mgper 3 Capsule(s)DSLD:248425
- ProCaps LaboratoriesChondroitin Sulfate 1200Calcium Chondroitin Sulfate · Chondroitin Sulfate (Form: from Calcium Chondroitin Sulfate)1,200 mgper 2 Capsule(s)DSLD:69597
- ProCaps LaboratoriesGlucosamine 1500 And Chondroitin 1200Calcium Chondroitin Sulfate · Chondroitin Sulfate (Form: from Calcium Chondroitin Sulfate)1,200 mgper 1 Capsule(s)DSLD:69576
- ProCaps LaboratoriesGlucosamine 1500 Chondroitin 1200Calcium Chondroitin Sulfate1,200 mgper 5 Capsule(s)DSLD:320124
- ProCaps LaboratoriesGlucosamine 1500 Chondroitin 1200 Bulk PowderCalcium Chondroitin Sulfate600 mgper 1.6 Gram(s)DSLD:320125
- ProCaps LaboratoriesGlucosamine 1500 Chondroitin 1200 plus UC-IICalcium Chondroitin Sulfate1,200 mgper 5 Capsule(s)DSLD:320126
- ProCaps LaboratoriesGlucosamine 1500 Chondroitin 1200 plus UC-IICalcium Chondroitin Sulfate1,200 mgper 1.7 Gram(s)DSLD:320127
- ProCaps LaboratoriesGlucosamine 1500 with Chondroitin 1200Calcium Chondroitin Sulfate1,200 mgper 2 Capsule(s)DSLD:275208
- ProCaps LaboratoriesGlucosamine with Chondroitin1,200 mgper 5 Capsule(s)DSLD:29559
- Professional BotanicalsArtho Joint Complex430 mgper 2 Capsule(s)DSLD:307978
- Professional BotanicalsJoint Complex450 mgper 2 Capsule(s)DSLD:274321
- Professional BotanicalsJoint Complex450 mgper 2 Capsule(s)DSLD:308990
- Professional BotanicalsLigatone Joint Complex500 mgper 2 Capsule(s)DSLD:200488
- Professional BotanicalsLigatone Joint Complex500 mgper 2 Capsule(s)DSLD:200679
- Progressive Professional from Progressive LaboratoriesG/C 1000500 mgper 2 Capsule(s)DSLD:261684
- Progressive Professional from Progressive LaboratoriesG/C 1000500 mgper 2 Capsule(s)DSLD:299169
- Progressive Professional from Progressive LaboratoriesGC-MSM 3550250 mgper 4 Capsule(s)DSLD:261763
- Progressive Professional from Progressive LaboratoriesRehab Forte50 mgper 2 Capsule(s)DSLD:263153
- Progressive Professional from Progressive LaboratoriesRehab Forte50 mgper 2 Capsule(s)DSLD:263154
- Protocol For Life BalanceGlucosamine & ChondroitinBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 2 Tablet(s)DSLD:73355
- Protocol For Life BalanceGlucosamine & Chondroitin With MSMBovine Cartilage · 1.2g1,200 mgper 3 Veg Capsule(s)DSLD:326440
- Protocol For Life BalanceGlucosamine & Chondroitin With MSMBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage) Note: 1,200 mg1.2 Gram(s)per 3 Capsule(s)DSLD:77421
- Protocol For Life BalanceLiquid Glucosamine & Chondroitin With MSM Citrus FlavorBovine Cartilage · Chondroitin Sodium Sulfate (Form: from Bovine Cartilage)600 mgper 1 TbspDSLD:69388
- PS ProSuppsVitaLinx500 mgper 5 Tablet(s)DSLD:67048
- Pure By NatureJoint Support150 mgper 3 Capsule(s)DSLD:276911
- Pure By NatureJoint Support150 mgper 3 Capsule(s)DSLD:277096
- Pure EncapsulationsChondroitin SulfateBovine · Chondroitin Sulfate (Form: from Bovine)800 mgper 2 Capsule(s)DSLD:184042
- Pure EncapsulationsGlucosamine Chondroitin with ManganeseBovine · Chondroitin Sulfate (Form: from Bovine)400 mgper 1 Capsule(s)DSLD:277680
- Pure EncapsulationsGlucosamine Chondroitin with ManganeseBovine400 mgper 1 Capsule(s)DSLD:299052
- Pure EncapsulationsGlucosamine HCl+ ChondroitinBovine · Chondroitin Sulfate (Form: from Bovine)300 mgper 1 Capsule(s)DSLD:182929
- Pure EncapsulationsGlucosamine HCl+ ChondroitinBovine · Chondroitin Sulfate (Form: from Bovine)300 mgper 1 Capsule(s)DSLD:277683
- Pure EncapsulationsGlucosamine+ Chondroitin with MSMBovine · Chondroitin Sulfate (Form: from Bovine)300 mgper 1 Capsule(s)DSLD:277689
- Pure EncapsulationsGlucosamine+ Chondroitin with MSMBovine · Chondroitin Sulfate (Form: from Bovine)300 mgper 1 Capsule(s)DSLD:277690
- Pure EncapsulationsGlucosamine+ Chondroitin with MSMBovine · Chondroitin Sulfate (Form: from Bovine)300 mgper 1 Capsule(s)DSLD:277691
- Pure EncapsulationsGlucosamine+ Chondroitin with MSMBovine · Chondroitin Sulfate (Form: from Bovine)300 mgper 1 Capsule(s)DSLD:277692
- Purely OptimalGlucosamine Chondroitin Turmeric + MSM1,200 mgper 3 Tablet(s)DSLD:243960
- Puritan's PrideGlucosamine Chondroitin1.2 g1,200 mgper 6 Tablet(s)DSLD:318142
- Puritan's PrideGlucosamine Chondroitin 750 mg/600 mgChondroitin Sulfate Note: 1.2 g1,200 mgper 2 Caplet(s)DSLD:285025
- Puritan's PrideGlucosamine Chondroitin 750 mg/600 mg1.2 g1,200 mgper 2 Caplet(s)DSLD:318143
- Puritan's PrideGlucosamine Chondroitin Complex800 mgper 2 Caplet(s)DSLD:12285
- Puritan's PrideGlucosamine Chondroitin MSM1.2 g1,200 mgper 3 Caplet(s)DSLD:318283
- Puritan's PrideGlucosamine Chondroitin with MSM200 mgper 3 Tablet(s)DSLD:71847
- Purity ProductsG.C. FlexBovine1,200 mgper 3 Capsule(s)DSLD:243751
- Purity ProductsJoint Formula Supreme600 mgper 4 Softgel(s)DSLD:243782
- Rite AidGlucosamine Chondroitin Complex200 mgper 2 Tablet(s)DSLD:320485
- Rite Aid PharmacyNatural Glucosamine/Chondroitin 500 mg/400 mgChondroitin Sulfate Sodium400 mgper 3 Capsule(s)DSLD:210096
- Rite Aid PharmacyNatural Glucosamine/Chondroitin/MSM 1500 mg/1200 mg/900 mg1,200 mgper 3 Caplet(s)DSLD:239774
- RoexCollagen II PlusBovine500 mgper 3 Vegetable Capsule(s)DSLD:279327
- Ron Teeguarden NutraceuticalsGlucosamine and Chondroitin Sulfate Plus1,200 mgper 3 Tablet(s)DSLD:316696
- RugbyGlucosamine, Chondroitin And MSM800 mgper 2 Caplet(s)DSLD:14454
- Rx VitaminsARTH-911.5 mgper 2 Capsule(s)DSLD:249066
- Rx VitaminsARTH-9Chondroitin Sulfate Note: pharmaceutical grade25 mgper 2 Capsule(s)DSLD:42049
- Safeway CareGlucosamine Chondroitin Complex Advanced200 mgper 3 Tablet(s)DSLD:26315
- Safeway CareGlucosamine Chondroitin Complex Advanced/Triple Strength200 mgper 2 Tablet(s)DSLD:26325
- SANGlucosamine Chondroitin with MSM1,200 mgper 3 Tablet(s)DSLD:305146
- SANGlucosamine Chondroitin With MSM1.2 Gram(s)per 3 Tablet(s)DSLD:175408
- SchiffJoint Care Plus Unflavored Drink Mix500 mgper 2 TbspDSLD:63723
- SchiffMove Free Advanced200 mgper 2 Tablet(s)DSLD:59742
- SchiffMove Free Advanced Glucosamine + Chondroitin1,500 mgper 2 Tablet(s)DSLD:241033
- SchiffMove Free Advanced MSM + Vitamin D3 with Glucosamine200 mgper 2 Tablet(s)DSLD:276909
- SchiffMove Free Advanced Plus MSM200 mgper 3 Tablet(s)DSLD:241040
- SchiffMove Free Advanced Plus MSM & Vitamin D3200 mgper 2 Tablet(s)DSLD:240939
- SchiffMove Free Advanced plus MSM & Vitamin D3 with Glucosamine + Chondroitin200 mgper 2 Tablet(s)DSLD:180278
- SchiffMove Free Advanced plus MSM + Vitamin D3200 mgper 2 Tablet(s)DSLD:277601
- SchiffMove Free Advanced Tablets200 mgper 2 Tablet(s)DSLD:180240
- SchiffMove Free Advanced with Glucosamine + Chondroitin200 mgper 2 Tablet(s)DSLD:180326
- SchiffMove Free Advanced With Glucosamine + Chondroitin200 mgper 2 Tablet(s)DSLD:180335
- SchiffMove Free Night200 mgper 2 Tablet(s)DSLD:59626
- Schiff Move FreeAdvanced Glucosamine Chondroitin Plus Uniflex & Joint Fluid200 mgper 2 Tablet(s)DSLD:63748
- Schiff Move FreeAdvanced With Glucosamine + Chondroitin200 mgper 2 Tablet(s)DSLD:63734
- Schiff Move FreeDouble StrengthChondroitin Sulfate Note: 1200 mg1.2 Gram(s)per 3 Tablet(s)DSLD:59625
- Schiff Move FreeGlucosamine Chondroitin Plus MSM200 mgper 3 Tablet(s)DSLD:63725
- Schiff Move FreeTriple Strength Glucosamine Chondroitin200 mgper 2 Tablet(s)DSLD:63732
- Schiff Move FreeTriple Strength Glucosamine Chondroitin200 mgper 2 Tablet(s)DSLD:63739
- Schiff Move Free Joint HealthAdvanced MSM with Glucosamine200 mgper 3 Tablet(s)DSLD:328316
- Schiff Move Free Joint Health Advanced Plus MSM & Vitamin D3200 mgper 2 Tablet(s)DSLD:264676
- SeniorLife HealthJoint Health Essentials125 mgper 2 Capsule(s)DSLD:2172
- SeniorLife HealthJoint Health Essentials100 mgper 2 Tablet(s)DSLD:256589
- ShopRiteDouble Strength Glucosamine 500 mg Chondroitin 400 mgChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Caplet(s)DSLD:67074
- ShopRiteDouble Strength Glucosamine 500 mg Chondroitin 400 mgChondroitin Sulfate Note: 1.2 g1,200 mgper 3 Caplet(s)DSLD:69444
- Signature SupplementsJoint Rebuild120 mgper 2 Capsule(s)DSLD:338798
- Simply BestGlucosamine 500 mg & Marine Chondroitin 400 mg 90%400 mgper 2 Capsule(s)DSLD:70382
- Simply BestGlucosamine 750 mg, Chondroitin 600 mg, Calcium 50 mgactive Chondroitin · Marine Chondroitin Sulphate (Form: providing 540 mg of 90% active Chondroitin)600 mgper 2 Capsule(s)DSLD:70819
- Simply SupplementsGlucosamine 500 mg & Marine Chondroitin 400 mg400 mgper 3 Capsule(s)DSLD:70166
- Simply SupplementsGlucosamine Sulphate, Chondroitin, Vitamin C And Calciumactive Marine Chondroitin · Marine Chondroitin Sulphate (Form: providing 20 mg of 20% active Marine Chondroitin)100 mgper 2 Capsule(s)DSLD:71065
- Simply SupplementsHigh Strength HSN Plusactive Chondroitin · Marine Chondroitin Sulphate (Form: providing 45 mg of 90% active Chondroitin)50 mgper 2 Capsule(s)DSLD:70746
- Simply SupplementsHigh Strength Marine Chondroitin Sulphate 200 mg200 mgper 2 Tablet(s)DSLD:70829
- Simply SupplementsSuper Strength Glucosamine 500 mg, Marine Chondroitin 100 mg & MSM 100 mgMarine Chondroitin Sulphate Note: providing112 mgper 1 Tablet(s)DSLD:70575
- Simply SupplementsSuper Strength Marine Chondroitin 750 mgMarine Chondroitin · Marine Chondroitin Sulphate (Form: providing 750 mg of active 90% Marine Chondroitin)835 mgper 2 Capsule(s)DSLD:71011
- SimplyBestGluChondrex Goldactive Chondroitin · Marine Chondroitin Sulphate (Form: providing 360 mg of 90% active Chondroitin)400 mgper 1 Capsule(s)DSLD:22502
- SimplyBestGluComplex Goldactive Chondroitin · Marine Chondroitin Sulphate (Form: providing 36 mg of 90% Active Chondroitin)40 mgper 1 Tablet(s)DSLD:22074
- SimplyBestGlucosamine 750 mg, Chondroitin 600 mg (90%) & Calcium 50 mgactive Chondroitin · Marine Chondroitin Sulphate (Form: providing 540 mg of 90% active Chondroitin)600 mgper 1 Capsule(s)DSLD:22507
- SimplyBestGlucosamine Sulphate 2KCl 500 mg & Chondroitin 400 mg (90%)active Chondroitin · Marine Chondroitin Sulphate (Form: providing 360 mg of 90% active Chondroitin)400 mgper 1 Capsule(s)DSLD:22505
- SimplySupplementsGlucosamine 500 mg, Marine Chondroitin 100 mg & MSM 100 mgMarine Chondroitin · Marine Chondroitin Sulphate (Form: providing 100 mg of 90% active Marine Chondroitin)112 mgper 1 Capsule(s)DSLD:22363
- SimplySupplementsGlucosamine Sulphate 2KCl 500 mg & Marine Chondroitin 400 mg (20%)Marine Chondroitin Sulphate Note: 20%400 mgper 1 Capsule(s)DSLD:22369
- SimplySupplementsHSN Plusactive Chondroitin · Marine Chondroitin Sulphate (Form: providing 45mg of 90% active Chondroitin)50 mgper 1 Capsule(s)DSLD:22419
- SimplySupplementsMarine Chondroitin 750 mgproviding 20mg of active Marine Chondroitin · Marine Chondroitin Sulphate (Form: providing 750mg of 90% providing 20mg of active Marine Chondroitin)835 mgper 1 Capsule(s)DSLD:22591
- SimplyValueGlucosamine Sulphate 750 mg, Marine Chondroitin 600 mg & Calcium 50 mgMarine Chondroitin · Marine Chondroitin Sulphate (Form: providing 120 mg of 20% active Marine Chondroitin)600 mgper 1 Capsule(s)DSLD:22244
- SolarayGlucosamine Chondroitin Hyaluronic AcidBovine1,000 mgper 3 VegCap(s)DSLD:325984
- SolgarChondroitin Sulfate 600 mgChondroitin Sulfate Sodium · Chrondroitin Sulfate (Form: as Chondroitin Sulfate Sodium)600 mgper 1 Tablet(s)DSLD:213964
- SolgarExtra Strength Glucosamine Chondroitin Complex1,500 mgper 3 Tablet(s)DSLD:218187
- SolgarExtra Strength Glucosamine Chondroitin Complex1,500 mgper 3 Tablet(s)DSLD:218189
- SolgarExtra Strength Glucosamine Chondroitin Complex1,500 mgper 3 Tablet(s)DSLD:218213
- SolgarExtra Strength Glucosamine Chondroitin MSM with Ester-CSodium Chondroitin Sulfate Note: 1.2 g1,200 mgper 3 Tablet(s)DSLD:201278
- SolgarExtra Strength Glucosamine Hyaluronic Acid Chondroitin MSM Shellfish-FreeChondroitin Sulfate Note: 1.2g1,200 mgper 3 Tablet(s)DSLD:201285
- SolgarExtra Strength Glucosamine Hyaluronic Acid Chondroitin MSM Shellfish-FreeChondroitin Sulfate Note: 1.2g1,200 mgper 3 Tablet(s)DSLD:201287
- SolgarTriple Strength Glucosamin Chondroitin MSMSodium Chondroitin Sulfate Note: 1.2 g1,200 mgper 2 Tablet(s)DSLD:218240
- SolgarTriple Strength Glucosamine Chondroitin MSMSodium Chondroitin Sulfate Note: 1.2 g1,200 mgper 2 Tablet(s)DSLD:218235
- Source NaturalsChondroitin Sulfate 400 mg800 mgper 2 Tablet(s)DSLD:274533
- Source NaturalsExtra Strength Glucosamine Chondroitin1.2 Gram(s)per 2 Tablet(s)DSLD:214182
- Source NaturalsExtra Strength Glucosamine Chondroitin1.2 Gram(s)per 2 Tablet(s)DSLD:214184
- Source NaturalsExtra Strength Glucosamine Chondroitin1.2 Gram(s)per 2 Tablet(s)DSLD:214216
- Source NaturalsExtra Strength Glucosamine Chondroitin1.2 Gram(s)per 2 Tablet(s)DSLD:273138
- Source NaturalsHyaluronic Joint ComplexBioCell Collagen600 mgper 2 Tablet(s)DSLD:273441
- Source NaturalsHyaluronic Joint Complex600 mgper 2 Tablet(s)DSLD:295847
- Spring ValleyDouble Strength Glucosamine ChondroitinChondroitin Sulfate Note: 1,200 mg1.2 Gram(s)per 3 Caplet(s)DSLD:26415
- Spring ValleyDouble Strength Glucosamine Chondroitin Soft Chews Orange Cream1.2 Gram(s)per 3 Chew(s)DSLD:65035
- Spring ValleyGlucosamine & Chondroitin Soft ChewsChondroitin Sulfate Note: 1,200 mg1.2 Gram(s)per 3 Chew(s)DSLD:26372
- Spring ValleyGlucosamine Chondroitin Plus MSMChondroitin Sulfate Note: 1,200 mg1.2 Gram(s)per 4 Caplet(s)DSLD:26419
- Spring ValleyTriple Strength Glucosamine 1500 mg Chondroitin 1200 mgChondroitin Sulfate Note: 1200 mg1.2 gper 2 Tablet(s)DSLD:12188
- Spring ValleyTriple Strength Glucosamine 1500 mg Chondroitin 1200 mg Plus MSM & Vitamin D3Chondroitin Sulfate Note: 1200 mg1.2 gper 2 Tablet(s)DSLD:12193
- Spring ValleyTriple Strength Glucosamine ChondroitinChondroitin Sulfate Sodium Note: 1.2 g1,200 mgper 2 Tablet(s)DSLD:239721
- Spring ValleyTriple Strength Glucosamine ChondroitinChondroitin Sulfate Sodium Note: 1.2 g1,200 mgper 2 Tablet(s)DSLD:239722
- Spring ValleyTriple Strength Glucosamine ChondroitinChondroitin Sulfate Sodium Note: 1.2 g1,200 mgper 2 Tablet(s)DSLD:239727
- Spring ValleyTriple Strength Glucosamine Chondroitin1,200 mgper 2 Tablet(s)DSLD:267982
- Spring ValleyTriple Strength Glucosamine Chondroitin1.2 Gram(s)per 2 Tablet(s)DSLD:83047
- StarlightLIFEGuard Joint Formula95%250 mgper 3 Tablet(s)DSLD:86024
- Success ChemistryHeight Fuel50 mgper 2 Capsule(s)DSLD:334298
- Sun TenArthroplex67 mgper 2 Capsule(s)DSLD:57987
- Sundown NaturalistGlucosamine ChondroitinChondroitin Sulfate Note: 1.2 g1,200 mgper 6 Tablet(s)DSLD:63394
- SunmarkGlucosamine Chondroitin Extra StrengthAvian Chondroitin Sulfate · Chondroitin Sulfate (Form: Bovine Chondroitin Sulfate, Porcine Chondroitin Sulfate, Avian Chondroitin Sulfate) Note: 1200 mg1.2 gper 3 Caplet(s)DSLD:7739
- Sunshine NaturalsGlucosamine Chondroitin plus MSM1,000 mgper 3 Capsule(s)DSLD:271247
- Sunshine NaturalsGlucosamine plus Chondroitin600 mgper 3 Capsule(s)DSLD:271244
- SuperSmartJoint Support Formulamarine origin1,200 mgper 3 Tablet(s)DSLD:332382
- SuppleSupple Natural Peach MangoChondroitin Sulfate Note: (bovine) (1,200 mg)1.2 Gram(s)per 237 mLDSLD:26143
- Supplement SpotGlucosamine with Chondroitin & MSM 4700 mgConsisting of1,200 mgper 5 Capsule(s)DSLD:264564
- Supplement SpotHealthy Joints100 mgper 2 Tablet(s)DSLD:264596
- SwansonGlucosamine & Chondroitin400 mgper 1 Capsule(s)DSLD:184811
- SwansonGlucosamine & Chondroitin250 mgper 1 Capsule(s)DSLD:202764
- SwansonGlucosamine & Chondroitin SulfateTruFlex Chondroitin Sulfate Note: USP600 mgper 1 Timed-Release Tablet(s)DSLD:184798
- SwansonGlucosamine & Chondroitin Timed-Release FormulaChondroitin Sulfate · USP600 mgper 1 Timed Release Tablet(s)DSLD:337751
- SwansonGlucosamine Chondroitin & MSM Higher Strength 3-in-1 FormulaChondroitin Sulfate Note: USP400 mgper 1 Tablet(s)DSLD:202812
- SwansonGlucosamine, Chondroitin & MSMChondroitin Sulfate Note: USP400 mgper 1 Tablet(s)DSLD:187553
- SwansonGlucosamine, Chondroitin & MSMChondroitin Sulfate Note: USP600 mgper 3 Tablet(s)DSLD:202903
- SwansonGlucosamine, Chondroitin & MSM600 mgper 6 Mini-Tablet(s)DSLD:337706
- SwansonGlucosamine, Chondroitin & MSM with Mobilee400 mgper 1 Capsule(s)DSLD:308588
- SwansonJoint Care66.67 mgper 1 Softgel(s)DSLD:266880
- SwansonJoint ComplexBovine Cartilage · Chondroitin Sulfate (Form: from Bovine Cartilage)200 mgper 1 Tablet(s)DSLD:191039
- SwansonMobility EssentialsTruFlex Chondroitin Sulfate Note: USP200 mgper 3 Veggie Capsule(s)DSLD:203293
- Swiss BioEnergeticsJoint Max Defence400 mgper 2 Tablet(s)DSLD:284283
- SynflexSynflex Glucosamine Complex25 mgper 3.75 mLDSLD:218669
- SynflexSynflex Glucosamine Complex 1500 Orange Flavor25 mgper 0.5 fl. Oz.DSLD:218673
- Terra OriginJoint & Bone200 mgper 2 Tablet(s)DSLD:313248
- TerraVitaAR Formula 2 - Glucosamine And Chondroitin Sulfate 450 mg225 mgper 1 Capsule(s)DSLD:17444
- TerraVitaChondroitin Sulfate 450 mg450 mgper 2 Capsule(s)DSLD:17275
- TerraVita Premium CollectionChondroitin Sulfate 450 mg450 mgper 1 Capsule(s)DSLD:285887
- TerraVita Premium CollectionChondroitin Sulfate Powder1,000 mgper 0.25 Teaspoon(s)DSLD:282026
- TerraVita Premium CollectionChondroitin Sulfate Powder1,000 mgper 0.25 Teaspoon(s)DSLD:290375
- The Vitamin ShoppeActive JointChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium)500 mgper 3 Capsule(s)DSLD:204829
- The Vitamin ShoppeActive JointChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium)500 mgper 3 Capsule(s)DSLD:204831
- The Vitamin ShoppeChondroitin Sulfate 500 mg500 mgper 1 Tablet(s)DSLD:35840
- The Vitamin ShoppeGlucosamine & Chondroitin Sulfate400 mgper 1 Tablet(s)DSLD:55523
- The Vitamin ShoppeGlucosamine & Chondroitin Sulfate400 mgper 1 Tablet(s)DSLD:55351
- The Vitamin ShoppeGlucosamine & Chondroitin With Quercetin And Bromelain400 mgper 2 Capsule(s)DSLD:35857
- The Vitamin ShoppeGlucosamine Chondroitin1,200 mgper 2 Tablet(s)DSLD:203502
- The Vitamin ShoppeGlucosamine Chondroitin400 mgper 3 Softgel(s)DSLD:245205
- The Vitamin ShoppeGlucosamine Chondroitin MSMChondroitin Sulfate Sodium · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium)500 mgper 3 Capsule(s)DSLD:183372
- The Vitamin ShoppeGlucosamine Chondroitin MSM400 mgper 2 Capsule(s)DSLD:203553
- The Vitamin ShoppeGlucosamine Chondroitin MSM400 mgper 2 Capsule(s)DSLD:203556
- The Vitamin ShoppeGlucosamine Chondroitin MSM400 mgper 2 Capsule(s)DSLD:203570
- The Vitamin ShoppeGlucosamine Chondroitin MSM RaspberryBovine600 mgper 1 Tablet(s)DSLD:184470
- The Vitamin ShoppeGlucosamine Chondroitin MSM RaspberryBovine600 mgper 1 Chewable Tablet(s)DSLD:299224
- The Vitamin ShoppeGlucosamine Chondroitin MSM Raspberry600 mgper 1 Wafer(s)DSLD:62938
- The Vitamin ShoppeGlucosamine Chondroitin Sulfate400 mgper 2 Softgel(s)DSLD:35137
- The Vitamin ShoppeGlucosamine Chondroitin Sulfate400 mgper 2 Softgel(s)DSLD:35139
- The Vitamin ShoppeGlucosamine Chondroitin Sulfate400 mgper 3 Softgel(s)DSLD:80391
- The Vitamin ShoppeGlucosamine Chondroitin Sulfate Grape600 mgper 1 Wafer(s)DSLD:35146
- The Vitamin ShoppeGlucosamine Chondroitin with MSM OrangeBovine300 mgper 15 mLDSLD:217979
- The Vitamin ShoppeGlucosamine Chondroitin with MSM OrangeBovine300 mgper 15 mLDSLD:217985
- The Vitamin ShoppeGlucosamine Chondroitin with MSM Triple StrengthChondroitin Sulfate Sodium Salt · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium Salt (Form: Bovine))1,200 mgper 2 Tablet(s)DSLD:217682
- The Vitamin ShoppeGlucosamine Chondroitin with MSM Triple StrengthChondroitin Sulfate Sodium Salt · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium Salt (Form: Bovine))1,200 mgper 2 Tablet(s)DSLD:217693
- The Vitamin ShoppeGlucosamine Chondroitin with MSM Triple StrengthChondroitin Sulfate Sodium Salt · Chondroitin Sulfate (Form: as Chondroitin Sulfate Sodium Salt (Form: Bovine))1,200 mgper 2 Tablet(s)DSLD:217702
- The Vitamin ShoppeUltimate Gold Joint Care600 mgper 2 Tablet(s)DSLD:208641
- The Vitamin ShoppeUltimate Gold Joint Care600 mgper 2 Tablet(s)DSLD:208888
- Thera-ZymeOSTEO50 mgper 2 Capsule(s)DSLD:177019
- ThompsonGluco-Pro 2XChondroitin Sulfate Calcium Note: bovine1,200 mgper 2 Tablet(s)DSLD:36350
- ThompsonGluco-Pro 9001.2 Gram(s)per 3 Tablet(s)DSLD:36716
- ThorneGlucosamine & ChondroitinBovine250 mgper 1 Capsule(s)DSLD:336356
- Thymely SolutionsGlucosamine Chondroitin Plus600 mgper 2 Veggie Cap(s)DSLD:211975
- Top CareAdvanced Glucosamine Chondroitin Complex200 mgper 2 Tablet(s)DSLD:73912
- Trace MineralsActivJoint Platinum600 mgper 6 Tablet(s)DSLD:274937
- Trace Minerals ResearchActivJoint Platinum600 mgper 2 Tablet(s)DSLD:57393
- Trace Minerals ResearchActivJoint Tangerine500 mgper 1 Packet(s)DSLD:43517
- Trace Minerals ResearchActivJoint Tangerine500 mgper 1 Packet(s)DSLD:57199
- Trace Minerals ResearchGlucosamine Chondroitin & MSM with ConcenTrace800 mgper 2 Tablet(s)DSLD:57042
- Trace Minerals ResearchGlucosamine/Chondroitin/MSM Blueberry750 mgper 1 Tablespoon(s)DSLD:43787
- Trace Minerals ResearchGlucosamine/Chondroitin/MSM Blueberry750 mgper 1 TbspDSLD:43792
- Trace Minerals ResearchGlucosamine/Chondroitin/MSM Blueberry750 mgper 1 TbspDSLD:57117
- Trace Minerals ResearchLiquid Active Joint Platinum Tangerine Flavor500 mgper 2 TbspDSLD:51785
- Trace Minerals ResearchLiquid ActivJoint Platinum Tangerine Flavor500 mgper 2 Tablespoon(s)DSLD:57407
- Trader Joe'sGlucosamine & ChondroitinBovine · Chondroitin Sulfate (Form: from Bovine)400 mgper 1 Caplet(s)DSLD:26787
- Trader Joe'sGlucosamine ChondroitinBovine or Chicken Source1,200 mgper 3 Tablet(s)DSLD:277467
- Trader Joe'sJoint SupportBovine source200 mgper 1 Capsule(s)DSLD:207387
- Traditional NutritionalsCMO PlusShark Cartilage · Chondroitin Sulfate (Form: from Shark Cartilage)50 mgper 2 Capsule(s)DSLD:11461
- Tropical OasisGlucosamine Chondroitin800 mgper 0.5 Fluid Ounce(s)DSLD:219378
- Tropical OasisJoint Complete800 mgper 1 Fluid Ounce(s)DSLD:219382
- Tropical OasisJoint Complete Premium Plus800 mgper 30 mLDSLD:295289
- U.S. NutritionTriple Strength Glucosamine 750 mg Chondroitin 600 mgChondroitin Sulfate Note: 1.2 g1,200 mgper 2 Tablet(s)DSLD:4319
- Ultimate Nutrition Platinum SeriesGlucosamine Chondroitin MSMChondroitin Sulfate Sodium1,200 mgper 3 Tablet(s)DSLD:293459
- UnicityGlucosamine AJF300 mgper 2 Capsule(s)DSLD:73159
- UniversalJointment Sport200 mgper 6 Capsule(s)DSLD:38287
- Universal Nutrition / Universal NaturalsJointment OS100 mgper 6 Tablet(s)DSLD:37776
- Universal Nutrition / Universal NaturalsJointment OS100 mgper 6 Tablet(s)DSLD:38216
- up&upGlucosamine Chondroitin Complex plus MSM200 mgper 3 Tablet(s)DSLD:20034
- up&upGlucosamine HCl 1,500 mg Chondroitin Sulfate 1,200 mg1.2 g1,200 mgper 2 Tablet(s)DSLD:277420
- VAXAArthritinBovine100 mgper 2 Capsule(s)DSLD:73699
- Vibrant HealthJoint Vibrance Orange PineappleBovine500 mgper 17.7 Gram(s)DSLD:71443
- Village VitalityGlucosamine Chondroitin MSM300 mgper 1 Tablet(s)DSLD:310227
- Village VitalityGlucosamine Chondroitin Plus600 mgper 2 Cap(s)DSLD:310228
- Vimerson HealthGlucosamine Chondroitin Turmeric & MSM150 mgper 1 Capsule(s)DSLD:315511
- Vimerson HealthGlucosamine Collagen Boswellia + MSM200 mgper 1 Capsule(s)DSLD:315512
- Vimerson HealthGlucosamine Vitamin D3 Chondroitin + MSM300 mgper 2 Tablet(s)DSLD:276908
- VitabaseGlucosamine Chondroitin And MSMChondroitin Sulfate Note: 90%1,200 mgper 1 Oz(s)DSLD:7825
- VitabaseGlucosamine/Chondroitin/MSMconsisting of1,200 mgper 5 Capsule(s)DSLD:329275
- VitabaseSuper Joint Formula400 mgper 1 Tablet(s)DSLD:6701
- VitaBreezeGlucosamine Chondroitin MSM & TurmericChondroitin Sulfate Sodium1,000 mgper 4 Capsule(s)DSLD:261834
- VitaBreezeGlucosamine Chondroitin MSM & TurmericChondroitin Sulfate Sodium1,000 mgper 4 Capsule(s)DSLD:268037
- VitaBreezeGlucosamine Chondroitin MSM & TurmericChondroitin Sulfate Sodium500 mgper 2 Capsule(s)DSLD:300078
- VitaCeutical LabsGlucosamine ChondroitinBeef Cartilage extract · Chondroitin Sulfate (Form: from Beef Cartilage extract)400 mgper 1 Tablet(s)DSLD:53873
- VitaCeutical LabsGlucosamine Chondroitin CompleteChondroitin Sulfate Note: 1500 mg1.5 Gram(s)per 3 Tablet(s)DSLD:53531
- VitaCeutical LabsGlucosamine Chondroitin CompleteChondroitin Sulfate Note: 1500 mg1.5 Gram(s)per 3 Tablet(s)DSLD:59447
- VitaCeutical LabsGlucosamine Chondroitin MSM300 mgper 1 Tablet(s)DSLD:6452
- VitaCeutical LabsJoint Support Softgels1,200 mgper 1 Softgel(s)DSLD:53858
- VitaCeutical LabsRegenerAge150 mgper 3 Capsule(s)DSLD:53944
- VitacostGlucosamine Chondroitin & MSM1,200 mgper 4 Capsule(s)DSLD:207644
- VitacostTriple Strength Glucosamine & Chondroitin 1,500 mg / 1,200 mgChondroitin Sulfate Sodium1,200 mgper 3 Capsule(s)DSLD:207732
- Vital Earth MineralsVital Joint Support Natural Wild Berry FlavorBovine Cartilage · USP1,000 mgper 30 mLDSLD:282480
- Vital NutrientsChondroitin Sulfate 400 mgChondroitin Sulfate Sodium Note: 80-90%400 mgper 1 Capsule(s)DSLD:27344
- Vital NutrientsGlucosamine & Chondroitin600 mgper 2 Capsule(s)DSLD:304991
- VitalBulkGlucosamine Chondroitin MSM900 mgper 3 Tablet(s)DSLD:28282
- VitalsUltra Joint Flex150 mgper 3 Capsule(s)DSLD:316205
- Vitamer LaboratoriesGlucosamine Chondroitin CompleteChondroitin Sulfate Note: 1.5 g1,500 mgper 3 Tablet(s)DSLD:23002
- Vitamer LaboratoriesGlucosamine Chondroitin MSM300 mgper 1 Tablet(s)DSLD:69246
- Vitamer LaboratoriesJoint Support Softgels1,200 mgper 1 Softgel(s)DSLD:67634
- Vitamer LaboratoriesRegenerAge150 mgper 3 Capsule(s)DSLD:68737
- Vitamin Research ProductsNutri-JointBioCell Collagen · Chondroitin Sulfate (Form: from bovine cartilage, and BioCell Collagen(R))648 mgper 4 Capsule(s)DSLD:34054
- Vitamin WorldJoint Soother Mini Tabs1,200 mgper 6 Tablet(s)DSLD:1322
- Vitamin WorldMega Vita Woman 50+ High Potency25 mgper 2 Tablet(s)DSLD:3274
- Vitamin WorldTriple Strength Glucosamine 750 mg Chondroitin 600 mgChondroitin Sulfate Note: 1.2 g1,200 mgper 2 Caplet(s)DSLD:21300
- Vitamin WorldUltra Vita Man 50+25 mgper 2 Tablet(s)DSLD:3275
- VitaScriptRegenerage Collagen Complete150 mgper 3 Capsule(s)DSLD:319244
- Viva NaturalsJoint SupportHalal Sourced Ingredient200 mgper 3 Capsule(s)DSLD:309776
- Viva VitaminsJoint Care Supreme300 mgper 1 Capsule(s)DSLD:238719
- Viva VitaminsJoint Support Supreme750 mgper 3 Tablet(s)DSLD:1761
- VostokGlucosamine Chondroitin150 mgper 3 Capsule(s)DSLD:310103
- WellesseJoint Movement Glucosamine Natural Berry Flavor1,200 mgper 2 TbspDSLD:4299
- Whole FoodsGlucosamine Chondroitin Complex600 mgper 2 Capsule(s)DSLD:26526
- WholeHealthGlucosamine + Chondroitin + MSM1,200 mgper 3 Capsule(s)DSLD:248481
- Wholly YouJoint Health250 mgper 2 Tablet(s)DSLD:275737
- WindmillGlucosamine with Chondroitin & MSM200 mgper 2 Tablet(s)DSLD:333554
- WindmillTriple Strength Glucosamine with Chondroitin & MSM1,200 mgper 3 Tablet(s)DSLD:181105
- Wonder LaboratoriesChondroitin Sulfate 500 mgCartilage Extract · Natural500 mgper 1 Capsule(s)DSLD:260431
- Wonder LaboratoriesChondroitin Sulfate 500 mgCartilage Extract · Natural cartilage extract500 mgper 1 Capsule(s)DSLD:262267
- Wonder LaboratoriesChondroitin Sulfate 850 mgCartilage Extract · chondroitin sulfate (from natural cartilage extract)850 mgper 0.5 Teaspoon(s)DSLD:260882
- Wonder LaboratoriesGlucosamine Chondroitin 2X Double Strength400 mgper 1 Capsule(s)DSLD:215263
- Wonder LaboratoriesGlucosamine Chondroitin 2X Double Strength400 mgper 1 Capsule(s)DSLD:215265
- Wonder LaboratoriesGlucosamine Chondroitin 2X Double Strength400 mgper 1 Capsule(s)DSLD:262248
- Wonder LaboratoriesGlucosamine Chondroitin 2X Double Strength400 mgper 1 Capsule(s)DSLD:262415
- Wonder LaboratoriesGlucosamine Chondroitin 2X Double Strength400 mgper 1 Capsule(s)DSLD:263904
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:256175
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:260475
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:262357
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:262359
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:262360
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:315282
- Wonder LaboratoriesGlucosamine Chondroitin 3X Triple Strength600 mgper 1 Tablet(s)DSLD:315394
- Wonder LaboratoriesGlucosamine Chondroitin M.S.M.1,200 mgper 3 Tablet(s)DSLD:260577
- Wonder LaboratoriesGlucosamine Chondroitin M.S.M.1,200 mgper 3 Tablet(s)DSLD:262088
- Wonder LaboratoriesGlucosamine Chondroitin M.S.M.1,200 mgper 3 Tablet(s)DSLD:315191
- Wonder LaboratoriesJoint / Health200 mgper 2 Capsule(s)DSLD:262906
- Wonder LaboratoriesJoint / Health200 mgper 2 Capsule(s)DSLD:262530
- Wonder LaboratoriesJoint / Health200 mgper 2 Capsule(s)DSLD:262531
- Wonder LaboratoriesJoint / Health200 mgper 2 Capsule(s)DSLD:262532
- Wonder LaboratoriesJoint Aid w/ Omega 3-6-9200 mgper 1 Softgel(s)DSLD:260885
- Wonder LaboratoriesJoint Pro All 4 Plus430 mgper 2 Capsule(s)DSLD:215301
- Wonder LaboratoriesJoint Pro All 4 Plus430 mgper 2 Capsule(s)DSLD:215303
- Wonder LaboratoriesJoint Pro All 4 Plus430 mgper 2 Capsule(s)DSLD:262985
- Wonder LaboratoriesJoint Pro All 4 Plus430 mgper 2 Capsule(s)DSLD:262986
- Wonder LaboratoriesJoint Pro All 4 Plus430 mgper 2 Capsule(s)DSLD:262987
- Wonder LaboratoriesJointXtra48 mgper 1 Capsule(s)DSLD:262900
- Wonder LaboratoriesJointXtra48 mgper 1 Capsule(s)DSLD:262901
- Wonder LaboratoriesJointXtra48 mgper 1 Capsule(s)DSLD:260883
- Wonder LaboratoriesJointXtra48 mgper 1 Capsule(s)DSLD:315206
- Wonder LaboratoriesMOBIFLEX+ Maximum Strength800 mgper 2 Tablet(s)DSLD:215499
- Wonder LaboratoriesMOBIFLEX+ Maximum Strength800 mgper 2 Tablet(s)DSLD:215509
- Wonder LaboratoriesSuper GCM400 mgper 2 Capsule(s)DSLD:262478
- Wonder LaboratoriesSuper GCM400 mgper 2 Capsule(s)DSLD:260581
- Wonder LaboratoriesSuper GCM400 mgper 2 Capsule(s)DSLD:315255
- Wonder LaboratoriesSuper GCM400 mgper 2 Capsule(s)DSLD:315429
- Wonder LaboratoriesSureflex400 mgper 2 Capsule(s)DSLD:262526
- Wonder LaboratoriesSureflex400 mgper 2 Capsule(s)DSLD:262528
- Wonder LaboratoriesSureFlex400 mgper 2 Capsule(s)DSLD:315430
- Woodstock VitaminsGlucosamine ChondroitinBeef Cartilage extract400 mgper 1 Tablet(s)DSLD:263063
- Woodstock VitaminsVital Joint Series NourishChondroitin Sulfate300 mgper 2 Capsule(s)DSLD:310339
- Woodstock VitaminsVital Joint Series Ultra Pure Glucosamine Chondroitin MSNChondroitin Sulfate600 mgper 2 Capsule(s)DSLD:310341
- XenduranceJoint-4600 mgper 3 Capsule(s)DSLD:243998
- XtendlifeArthrit-EzeShark Cartilage · Chondroitin Sulfate (Form: from Shark cartilage)390 mgper 6 Tablet(s)DSLD:17012
- XYMOGENSynovX DJDChondroitin Sulfate Sodium300 mgper 2 Capsule(s)DSLD:294825
- XYMOGENSynovX RecoveryChondroitin Sulfate600 mgper 2 Capsule(s)DSLD:303847
- Yes You Can!Joint Health UnflavoredChondroitin Sulfate Sodium400 mgper 2 Tablet(s)DSLD:258632
- YoungevityBeyond Tangy Tangerine25 mgper 13.9 Gram(s)DSLD:209087
- YoungevityBeyond Tangy Tangerine 2.025 mgper 4 Tablet(s)DSLD:209214
- YoungevityBeyond Tangy Tangerine 2.0 Citrus Peach Fusion25 mgper 16 Gram(s)DSLD:209347
- YoungevityUltimate Daily14 mgper 2 Tablet(s)DSLD:81796
- Zenesis LabsGlucosamine Chondroitin MSM1,200 mgper 5 Capsule(s)DSLD:267994
- Zenwise HealthJoint Support1,200 mgper 3 Tablet(s)DSLD:229219
- Zenwise LabsJoint Support1,200 mgper 3 Tablet(s)DSLD:267979
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- chondroitin sulfate
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
72 trials
72 registered trials without posted results · Overdue (FDAAA 801): 66
66 past the window6 within it, or no actual date
- NCT07738692completed2026-04-30a university or hospital
- NCT07746466completed2025-08-15a university or hospitalpast the reporting window
- NCT05687019completed2025-06-24a university or hospitalpast the reporting window
- NCT06623773completed2024-10-28industrypast the reporting window
- NCT05995626completed2024-09-24a university or hospitalpast the reporting window
- NCT06798428completed2024-03-01a government bodypast the reporting window
- NCT06659016completed2024-02-10a university or hospitalpast the reporting window
- NCT05474586completed2023-07-04industrypast the reporting window
- NCT06032442completed2023-05-18industrypast the reporting window
- NCT05613660completed2023-04-30a university or hospitalpast the reporting window
- NCT05799456completed2023-02-28a university or hospitalpast the reporting window
- NCT05400291completed2022-12-31a university or hospitalpast the reporting window
Show the remaining 60
- NCT04202692completed2022-11-23industrypast the reporting window
- NCT05322148completed2022-11-17industrypast the reporting window
- NCT04661267completed2022-10-31industrypast the reporting window
- NCT05323370completed2022-10-30a university or hospitalpast the reporting window
- NCT06573606completed2022-09-01industrypast the reporting window
- NCT05385562completed2022-05-01a university or hospitalpast the reporting window
- NCT05464953completed2022-04-20a university or hospitalpast the reporting window
- NCT05321836completed2022-03-25a university or hospitalpast the reporting window
- NCT05345808completed2022-02-20a university or hospitalpast the reporting window
- NCT07476508completed2021-12-31a university or hospitalpast the reporting window
- NCT03883074completed2021-09-16industrypast the reporting window
- NCT05223946completed2021-05-01a university or hospitalpast the reporting window
- NCT04470336completed2021-02-24industrypast the reporting window
- NCT04063644completed2020-12-22industrypast the reporting window
- NCT04665804completed2020-12-06a university or hospitalpast the reporting window
- NCT03945110completed2020-09-22a university or hospitalpast the reporting window
- NCT04654871completed2020-09-01a university or hospitalpast the reporting window
- NCT03762408completed2020-05-29industrypast the reporting window
- NCT04664712completed2020-05-01a university or hospitalpast the reporting window
- NCT03463499completed2019-09-30a university or hospitalpast the reporting window
- NCT02830919completed2019-05-10industrypast the reporting window
- NCT03963323completed2019-03-31a university or hospitalpast the reporting window
- NCT03971968completed2019-02-14a university or hospitalpast the reporting window
- NCT03827161completed2018-12-01a university or hospitalpast the reporting window
- NCT04358120completed2018-09-18industrypast the reporting window
- NCT03731793completed2018-06-30a university or hospitalpast the reporting window
- NCT02366676completed2018-01a university or hospitalpast the reporting window
- NCT02178137completed2017-09a university or hospitalpast the reporting window
- NCT03355651completed2017-02-01industrypast the reporting window
- NCT01813565terminated— No benefit of intravesical instillation of Hyaluronic Acid/Chondroitin Sulfate2016-12-01a university or hospitalpast the reporting window
- NCT01966029completed2016-07industrypast the reporting window
- NCT02865031completed2016-07a university or hospitalpast the reporting window
- NCT04352322completed2016-07a university or hospitalpast the reporting window
- NCT02079727completed2015-10-19industrypast the reporting window
- NCT02562833completed2015-02a university or hospitalpast the reporting window
- NCT02304861completed2014-06a university or hospitalpast the reporting window
- NCT04268810terminated— too many side effect in the control arm (DMSO)2013-09a university or hospitalpast the reporting window
- NCT01682694completed2013-08a university or hospitalpast the reporting window
- NCT01990729completed2013-01industrypast the reporting window
- NCT01298973completed2012-01industrypast the reporting window
- NCT03209895completed2011-06-13industrypast the reporting window
- NCT02010918completed2010-11industrypast the reporting window
- NCT00805519completed2010-04a university or hospitalpast the reporting window
- NCT00604539completed2009-11industrypast the reporting window
- NCT00860873completed2009-11industrypast the reporting window
- NCT00527917completed2008-06industrypast the reporting window
- NCT01271218completed2006-12a university or hospitalpast the reporting window
- NCT00198471completed2006-11industrypast the reporting window
- NCT00298441completed2006-05a university or hospitalpast the reporting window
- NCT00198549completed2005-01industrypast the reporting window
- NCT00198484completed2004-12industrypast the reporting window
- NCT00198458completed2004-07industrypast the reporting window
- NCT00198419completed2004-03industrypast the reporting window
- NCT00198497completed2001-09industrypast the reporting window
- NCT00198510completed2001-09industrypast the reporting window
- NCT00032890completedno completion dateUS federal agency
- NCT00048620completedno completion dateindustry
- NCT00048711completedno completion dateindustry
- NCT00086229completedno completion dateNIH
- NCT00669123completedno completion dateindustry
Papers screened
1,540 papers
- Compound
- chondroitin sulfate
- Screened
- 1,540
- Admitted
- 6
- Discarded
- 1,161
- Not read
- 373
- Showing
- 200 of 1,540
Produced a finding6 papers
and 6 more.
Read and discarded1,161 papers
- PMID:21566795cited by PMID:25686272; not about the subject it would be filed under2026-10-17
- PMID:22566220cited by PMID:25686272; not about the subject it would be filed under2026-10-17
- PMID:22964140cited by PMID:25686272; not about the subject it would be filed under2026-10-17
- PMID:3242815cited by PMID:25686272; not about the subject it would be filed under2026-10-17
- PMID:3472198cited by PMID:25686272; not about the subject it would be filed under2026-10-17
- PMID:15199558cited by PMID:25648510; not about the subject it would be filed under2026-10-17
- PMID:18023703cited by PMID:25648510; not about the subject it would be filed under2026-10-17
- PMID:23297815cited by PMID:25648510; not about the subject it would be filed under2026-10-17
- PMID:23385300cited by PMID:25648510; not about the subject it would be filed under2026-10-17
- PMID:23437168cited by PMID:25648510; not about the subject it would be filed under2026-10-17
- PMID:11728399cited by PMID:25648510; not about the subject it would be filed under2026-10-17
- PMID:16393445cited by PMID:25589511; not about the subject it would be filed under2026-10-17
and 1,149 more.
Not read yet373 papers
and 373 more.
Measured, not recorded
- Compound
- chondroitin sulfate
- Endpoints measured
- 918 endpoints
- Recorded as a finding
- No
Show what was measured
Between-group difference in mean reduction in pain VAS from baseline
decreases, p = 0.03
After 4 weeks the difference between active and placebo groups in their mean reduction from baseline was 1.2 (95% CI 0.1 to 2.4, p = 0.03)
PMID:12610812 · one of two readings recorded this
Between-group difference in mean reduction in pain VAS from baseline
decreases, p = 0.002
after 8 weeks was 1.8 (95% CI for difference between groups, 0.6 to 2.9 cm; p = 0.002)
PMID:12610812 · one of two readings recorded this
knee pain on a visual analog scale (cm) at 4 and 8 weeks, topical cream
decreases, mean change -3.4 cm vs -1.6 cm at 8 weeks
Not recorded as a finding: the intervention held more than the compound
VAS scores indicated a greater mean reduction in pain for the glucosamine/chondroitin preparation group (mean change -3.4 cm, SD 2.6 cm) compared to the placebo group (mean change -1.6 cm, SD 2.7 cm) after 8 weeks.
PMID:12610812 · one of two readings recorded this
knee pain on a visual analog scale (cm) at 4 and 8 weeks
decreases
Not recorded as a finding: the intervention held more than the compound
VAS scores indicated a greater mean reduction in pain for the glucosamine/chondroitin preparation group (mean change -3.4 cm, SD 2.6 cm) compared to the placebo group (mean change -1.6 cm, SD 2.7 cm) after 8 weeks.
PMID:12610812 · one of two readings recorded this
Mean change in knee pain VAS
decreases
VAS scores indicated a greater mean reduction in pain for the glucosamine/chondroitin preparation group (mean change -3.4 cm, SD 2.6 cm) compared to the placebo group (mean change -1.6 cm, SD 2.7 cm) after 8 weeks
PMID:12610812 · one of two readings recorded this
percentage of implants covered by new bone-like tissue after 4 to 6 months, histology
increases, 67% in group A vs 34% in group B
Not recorded as a finding: the intervention held more than the compound
After 4 to 6 months of healing, group A revealed higher percentages of implants covered by new, bone-like tissue (67% in group A, 34% in group B).
PMID:12956481 · one of two readings recorded this
percentage of implants covered by new bone-like tissue after 4 to 6 months, with histology
increases, 67% in group A vs 34% in group B
Not recorded as a finding: the intervention held more than the compound
After 4 to 6 months of healing, group A revealed higher percentages of implants covered by new, bone-like tissue (67% in group A, 34% in group B).
PMID:12956481 · one of two readings recorded this
Percentage of implants covered by new, bone-like tissue
increases
group A revealed higher percentages of implants covered by new, bone-like tissue (67% in group A, 34% in group B)
PMID:12956481 · one of two readings recorded this
Placental malaria in women with high antibody levels at term to CSP, LSA1 and RESA versus antibody-negative women
increases
women with high antibody levels at term to CSP, LSA1, and RESA were more likely to have placental malaria than antibody-negative women
PMID:14977967 · one of two readings recorded this
Placental malaria risk in women antibody-negative for MSP1-19 versus antibody-positive
increases, p = 0.007
Results showed that women who were antibody negative for MSP1-19 were at a higher risk of having placental malaria than women with antibodies (P < 0.007)
PMID:14977967 · one of two readings recorded this
Placental parasitemia in women with high levels of antibodies blocking infected-erythrocyte binding to chondroitin sulfate A
decreases, p = 0.02
an association between high levels of antibodies that blocked the binding of infected erythrocytes to CSA and low placental parasitemias was observed (P = 0.02)
PMID:14977967 · one of two readings recorded this
Difference in loss of mean joint space width between groups
increases, p = 0.04, n = 300
The differences in loss of joint space between the two groups were significant for mean joint space width (0.14 +/- 0.57 mm; P = 0.04)
PMID:15751094 · one of two readings recorded this
Difference in loss of minimum joint space width between groups
increases, p = 0.05, n = 300
minimum joint space width (0.12 +/- 0.52 mm; P = 0.05)
PMID:15751094 · one of two readings recorded this
joint space loss over 2 years on posteroanterior knee radiograph in flexion (mean and minimum joint space width), 800 mg CS once daily versus placebo
decreases, difference in mean JSW loss 0.14 mm; minimum JSW 0.12 mm, p = 0.04
Not recorded as a finding: the supporting sentence never names the compound
The differences in loss of joint space between the two groups were significant for mean joint space width (0.14 +/- 0.57 mm; P = 0.04) and for minimum joint space width (0.12 +/- 0.52 mm; P = 0.05).
PMID:15751094 · one of two readings recorded this
Mean joint space loss from baseline
decreases, p = 0.001, n = 150
The 150 patients receiving placebo had progressive joint space narrowing, with a mean +/- SD joint space loss of 0.14 +/- 0.61 mm after 2 years (P = 0.001 compared with baseline)
PMID:15751094 · one of two readings recorded this
Mean joint space width change from baseline
no effect, n = 150
there was no change in mean joint space width for the 150 patients receiving CS (0.00 +/- 0.53 mm; P not significant compared with baseline)
PMID:15751094 · one of two readings recorded this
radiographic joint space width loss over 2 years, posteroanterior flexion radiograph (mean and minimum JSW)
decreases, difference 0.14 mm mean JSW, 0.12 mm minimum JSW
Not recorded as a finding: the between-group sentence never names the compound or CS arm; other sentences are within-arm only
The differences in loss of joint space between the two groups were significant for mean joint space width (0.14 +/- 0.57 mm; P = 0.04) and for minimum joint space width (0.12 +/- 0.52 mm; P = 0.05).
PMID:15751094 · one of two readings recorded this
Symptomatic effect (pain and function)
no effect
While there was no significant symptomatic effect in this study, long-term treatment with CS may retard radiographic progression in patients with OA of the knee
PMID:15751094 · one of two readings recorded this
Onset of significant response, Glu/CS versus carprofen
unclear
Onset of significant response was slower for Glu/CS than for carprofen-treated dogs
PMID:16647870 · one of two readings recorded this
Pain, weight-bearing and severity of condition scores (veterinarian-assessed)
decreases, p = 0.001
Dogs treated with Glu/CS showed statistically significant improvements in scores for pain, weight-bearing and severity of the condition by day 70 (P<0.001)
PMID:16647870 · one of two readings recorded this
veterinarian-rated scores for pain, weight-bearing and severity of osteoarthritis in dogs
increases, significant improvements in scores for pain, weight-bearing and severity by day 70
Not recorded as a finding: the intervention held more than the compound
Dogs treated with Glu/CS showed statistically significant improvements in scores for pain, weight-bearing and severity of the condition by day 70 (P<0.001).
PMID:16647870 · one of two readings recorded this
veterinarian-scored pain, weight-bearing and severity of osteoarthritis in dogs by day 70
decreases
Not recorded as a finding: the intervention held more than the compound
Dogs treated with Glu/CS showed statistically significant improvements in scores for pain, weight-bearing and severity of the condition by day 70 (P<0.001).
PMID:16647870 · one of two readings recorded this
biochemical markers of bone (CTX-I), cartilage (CTX-II) and synovium (hyaluronic acid) metabolism
no effect
No significant difference was observed between treatment groups for changes in biomarkers over 24 weeks.
PMID:17204566 · one of two readings recorded this
biomarkers of bone (CTX-I), cartilage (CTX-II) and synovium (hyaluronic acid) turnover
no effect
No significant difference was observed between treatment groups for changes in biomarkers over 24 weeks.
PMID:17204566 · one of two readings recorded this
investigator's global assessment and SF-12 physical component improvement frequency
increases
Not recorded as a finding: bundles two distinct instruments (investigator's assessment and SF-12 physical component) under one shared statement with two separate p-values; not separable into a single-endpoint claim
The investigator's assessments and short form 12 (SF-12) physical component reported improvement more frequently in the chondroitin sulphate than in the placebo group (p = 0.044 and 0.021, respectively).
PMID:17204566 · one of two readings recorded this
investigator's global assessment and SF-12 physical component
increases, reported improvement more frequently in chondroitin sulphate than placebo
The investigator's assessments and short form 12 (SF-12) physical component reported improvement more frequently in the chondroitin sulphate than in the placebo group (p = 0.044 and 0.021, respectively).
PMID:17204566 · one of two readings recorded this
Lequesne's index (function)
-2.4 (chondroitin) vs -1.7 (placebo) points improvement
At the end of treatment, the decrease in pain was -26.2 (24.9) and -19.9 (23.5) mm and improved function was -2.4 (3.4) (-25%) and -1.7 (3.3) (-17%) in the chondroitin sulphate and placebo groups, respectively (p = 0.029 and 0.109).
PMID:17204566 · one of two readings recorded this
OMERACT-OARSI responder rate
68% responders in the chondroitin sulphate group vs 56% in the placebo group, p = 0.03
Not recorded as a finding: no matching outcome node for the OMERACT-OARSI response criterion
The OMERACT-OARSI responder rate was 68% in the chondroitin sulphate and 56% in the placebo group (p = 0.03).
PMID:17204566 · one of two readings recorded this
OMERACT-OARSI responder rate
68% responders (chondroitin sulphate) vs 56% (placebo)
The OMERACT-OARSI responder rate was 68% in the chondroitin sulphate and 56% in the placebo group (p = 0.03).
PMID:17204566 · one of two readings recorded this
pain decrease (visual analogue scale, mm)
-26.2 mm (chondroitin sulphate) vs -19.9 mm (placebo) decrease in pain
Not recorded as a finding: sentence reports two signed magnitudes (-26.2 vs -19.9 mm) with no comparative direction word; direction not stated in words
At the end of treatment, the decrease in pain was -26.2 (24.9) and -19.9 (23.5) mm and improved function was -2.4 (3.4) (-25%) and -1.7 (3.3) (-17%) in the chondroitin sulphate and placebo groups, respectively (p = 0.029 and 0.109).
PMID:17204566 · one of two readings recorded this
pain on daily activities (VAS) and Lequesne's Index (primary efficacy criteria)
pain decrease -26.2mm (chondroitin sulphate) vs -19.9mm (placebo); function improved -2.4 vs -1.7 points, respectively, n = 307
Not recorded as a finding: the direction is carried only as a signed number
At the end of treatment, the decrease in pain was -26.2 (24.9) and -19.9 (23.5) mm and improved function was -2.4 (3.4) (-25%) and -1.7 (3.3) (-17%) in the chondroitin sulphate and placebo groups, respectively (p = 0.029 and 0.109).
PMID:17204566 · one of two readings recorded this
pain on daily activities (VAS) and Lequesne's Index
pain decrease -26.2mm (chondroitin sulphate) vs -19.9mm (placebo); function improved -2.4 vs -1.7 points, respectively, n = 307
At the end of treatment, the decrease in pain was -26.2 (24.9) and -19.9 (23.5) mm and improved function was -2.4 (3.4) (-25%) and -1.7 (3.3) (-17%) in the chondroitin sulphate and placebo groups, respectively (p = 0.029 and 0.109).
PMID:17204566 · one of two readings recorded this
pain (visual analogue scale)
-26.2 mm (chondroitin) vs -19.9 mm (placebo) decrease in pain
At the end of treatment, the decrease in pain was -26.2 (24.9) and -19.9 (23.5) mm and improved function was -2.4 (3.4) (-25%) and -1.7 (3.3) (-17%) in the chondroitin sulphate and placebo groups, respectively (p = 0.029 and 0.109).
PMID:17204566 · one of two readings recorded this
Any adverse event
no effect
A meta-analysis of 12 trials showed a pooled relative risk of 0.99 (CI, 0.76 to 1.31) for any adverse event
PMID:17438317 · one of two readings recorded this
osteoarthritis pain, effect size (difference in means divided by pooled SD) pooled across trials; pain instruments mixed
Not recorded as a finding: every result is a subgroup, with no whole-population estimate
This resulted in an effect size of -0.03 (95% CI, -0.13 to 0.07; I2 = 0%) and corresponded to a difference of 0.6 mm on a 10-cm visual analogue scale.
PMID:17438317 · one of two readings recorded this
osteoarthritis pain, effect size pooled across pain-related outcomes (differences in means divided by pooled SD)
Not recorded as a finding: every result is a subgroup, with no whole-population estimate
This resulted in an effect size of -0.03 (95% CI, -0.13 to 0.07; I2 = 0%) and corresponded to a difference of 0.6 mm on a 10-cm visual analogue scale.
PMID:17438317 · one of two readings recorded this
Pain, all trials pooled (heterogeneity)
unclear, n = 3846
20 trials (3846 patients) contributed to the meta-analysis, which revealed a high degree of heterogeneity among the trials (I2 = 92%)
PMID:17438317 · one of two readings recorded this
Pain, effect size
no effect
This resulted in an effect size of -0.03 (95% CI, -0.13 to 0.07; I2 = 0%) and corresponded to a difference of 0.6 mm on a 10-cm visual analogue scale
PMID:17438317 · one of two readings recorded this
Epithelial cell morphology (ECM), baseline CS-HA vs CsA
no effect, p = 0.688
with no significant difference between the two groups (p=0.795, 0.333, and 0.688, respectively)
PMID:18063881 · one of two readings recorded this
Epithelial cell morphology (ECM) change, CS-HA vs CsA
no effect, p = 0.439
GCDs increased more prominently in topical CsA treated eyes than in topical CS-HA treated eyes (p=0.033), while NCR and ECM showed no significant difference (p=0.721 and 0.439, respectively)
PMID:18063881 · one of two readings recorded this
Epithelial cell morphology (ECM)
Before treatment, mean GCD, NCR, and ECM were 5.36±1.02, 3.27±0.97, and 4.25±0.61 in topical CS-HA treated eyes
PMID:18063881 · one of two readings recorded this
Epithelial cell morphology (ECM)
modulates, p = 0.018
After scheduled treatment with topical CS-HA, there was significant improvement of GCD, NCR, and ECM (p=0.047, 0.035, and 0.018, respectively)
PMID:18063881 · one of two readings recorded this
Epithelial cell morphology (ECM)
5.47±1.71, 3.53±0.61, and 4.59±0.78 in topical CsA treated eyes
PMID:18063881 · one of two readings recorded this
Epithelial cell morphology (ECM)
modulates, p = 0.027
Similarly, there was marked improvement of GCD, NCR, and ECM in topical CsA treated eyes (p=0.012, 0.025, and 0.027, respectively)
PMID:18063881 · one of two readings recorded this
Goblet cell density (GCD), baseline CS-HA vs CsA
no effect, p = 0.795
with no significant difference between the two groups (p=0.795, 0.333, and 0.688, respectively)
PMID:18063881 · one of two readings recorded this
Goblet cell density (GCD) increase, CS-HA vs CsA
decreases, p = 0.033
GCDs increased more prominently in topical CsA treated eyes than in topical CS-HA treated eyes (p=0.033), while NCR and ECM showed no significant difference (p=0.721 and 0.439, respectively)
PMID:18063881 · one of two readings recorded this
Goblet cell density (GCD)
Before treatment, mean GCD, NCR, and ECM were 5.36±1.02, 3.27±0.97, and 4.25±0.61 in topical CS-HA treated eyes
PMID:18063881 · one of two readings recorded this
Goblet cell density (GCD)
increases, p = 0.047
After scheduled treatment with topical CS-HA, there was significant improvement of GCD, NCR, and ECM (p=0.047, 0.035, and 0.018, respectively)
PMID:18063881 · one of two readings recorded this
Goblet cell density (GCD)
5.47±1.71, 3.53±0.61, and 4.59±0.78 in topical CsA treated eyes
PMID:18063881 · one of two readings recorded this
Goblet cell density (GCD)
increases, p = 0.012
Similarly, there was marked improvement of GCD, NCR, and ECM in topical CsA treated eyes (p=0.012, 0.025, and 0.027, respectively)
PMID:18063881 · one of two readings recorded this
Nucleus to cytoplasm ratio (NCR), baseline CS-HA vs CsA
no effect, p = 0.333
with no significant difference between the two groups (p=0.795, 0.333, and 0.688, respectively)
PMID:18063881 · one of two readings recorded this
Nucleus to cytoplasm ratio (NCR) change, CS-HA vs CsA
no effect, p = 0.721
GCDs increased more prominently in topical CsA treated eyes than in topical CS-HA treated eyes (p=0.033), while NCR and ECM showed no significant difference (p=0.721 and 0.439, respectively)
PMID:18063881 · one of two readings recorded this
Nucleus to cytoplasm ratio (NCR)
Before treatment, mean GCD, NCR, and ECM were 5.36±1.02, 3.27±0.97, and 4.25±0.61 in topical CS-HA treated eyes
PMID:18063881 · one of two readings recorded this
Nucleus to cytoplasm ratio (NCR)
modulates, p = 0.035
After scheduled treatment with topical CS-HA, there was significant improvement of GCD, NCR, and ECM (p=0.047, 0.035, and 0.018, respectively)
PMID:18063881 · one of two readings recorded this
Nucleus to cytoplasm ratio (NCR)
5.47±1.71, 3.53±0.61, and 4.59±0.78 in topical CsA treated eyes
PMID:18063881 · one of two readings recorded this
Nucleus to cytoplasm ratio (NCR)
modulates, p = 0.025
Similarly, there was marked improvement of GCD, NCR, and ECM in topical CsA treated eyes (p=0.012, 0.025, and 0.027, respectively)
PMID:18063881 · one of two readings recorded this
Schirmer test tear wetting, CS-HA vs CsA
no effect, p = 0.132
Although the amount of tear wetting tended to be greater in the 0.05% CsA group, there was no statistically significant difference between the two groups (p=0.132)
PMID:18063881 · one of two readings recorded this
Schirmer test tear wetting
no effect, p = 0.234
There was no significant difference of aqueous tear production between the two groups before treatment (5.72±1.72 seconds on topical CS-HA treated eyes and 6.17±1.56 seconds on topical CsA treated eyes) (p=0.234)
PMID:18063881 · one of two readings recorded this
Schirmer test tear wetting
increases, p = 0.024
Tear wetting increased significantly in both groups compared with pretreatment levels (6.47±1.68 seconds on topical CS-HA treated eyes and 7.17±1.56 seconds on topical 0.05% CsA treated eyes), (p=0.024 and 0.011, respectively)
PMID:18063881 · one of two readings recorded this
Schirmer test tear wetting
increases, p = 0.011
Tear wetting increased significantly in both groups compared with pretreatment levels (6.47±1.68 seconds on topical CS-HA treated eyes and 7.17±1.56 seconds on topical 0.05% CsA treated eyes), (p=0.024 and 0.011, respectively)
PMID:18063881 · one of two readings recorded this
tear film break-up time (BUT) in dry eye, CS-HA eyedrops versus 0.05% cyclosporine eyedrops in the fellow eye
p = 0.026
Not recorded as a finding: the comparison was against another active treatment
BUT increase was more prominent in the CsA group than in the CS-HS group (p=0.026, Fig. 1).
PMID:18063881 · one of two readings recorded this
Tear film break-up time (BUT) increase, CS-HA vs CsA
decreases, p = 0.026
BUT increase was more prominent in the CsA group than in the CS-HS group (p=0.026, Fig. 1)
PMID:18063881 · one of two readings recorded this
Tear film break-up time (BUT)
no effect, p = 0.623
Before eyedrop application, there was no significant difference of tear film BUT between each group of eyes (4.19±0.86 seconds on CS-HA-treated eyes and 4.08±1.01 seconds on CsA-treated eyes, p=0.623)
PMID:18063881 · one of two readings recorded this
Tear film break-up time (BUT)
increases, p = 0.041
After scheduled applications, there was significant prolongation of tear film BUT in both groups (4.39±1.12 sec on CS-HA-treated eyes and 5.08±0.77 on CsA-treated eyes), (p=0.041 and 0.029, respectively)
PMID:18063881 · one of two readings recorded this
Tear film break-up time (BUT)
increases, p = 0.029
After scheduled applications, there was significant prolongation of tear film BUT in both groups (4.39±1.12 sec on CS-HA-treated eyes and 5.08±0.77 on CsA-treated eyes), (p=0.041 and 0.029, respectively)
PMID:18063881 · one of two readings recorded this
knee joint swelling, investigator-assessed presence or absence at study visits
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Additionally, patients taking chondroitin sulfate were noted to have a statistically significant improvement in knee joint swelling.
PMID:18768335 · one of two readings recorded this
knee joint swelling, investigator-assessed presence or absence
decreases
Additionally, patients taking chondroitin sulfate were noted to have a statistically significant improvement in knee joint swelling.
PMID:18768335 · one of two readings recorded this
SF-36 Physical Component Summary score at 2 years
no effect, p = 0.93
The SF-36 Physical Component Summary scores were 37.0+/-11.4 and 37.2+/-10.6, respectively (absolute difference, -0.2+/-11.1; 95% CI, -3.6 to 3.2; P=0.93)
PMID:18784099 · one of two readings recorded this
Total WOMAC score at 2 years, between-arm absolute difference
no effect, p = 0.22
absolute difference [surgery-group score minus control-group score], -23+/-605; 95% confidence interval [CI], -208 to 161; P=0.22
PMID:18784099 · one of two readings recorded this
total WOMAC score at 2 years (range 0 to 2400) and SF-36 Physical Component Summary, arthroscopic surgery versus physical and medical therapy alone
no effect, WOMAC 874 vs 897, absolute difference -23 (95% CI -208 to 161), p = 0.22
Not recorded as a finding: subject_absent
After 2 years, the mean (+/-SD) WOMAC score for the surgery group was 874+/-624, as compared with 897+/-583 for the control group (absolute difference [surgery-group score minus control-group score], -23+/-605; 95% confidence interval [CI], -208 to 161; P=0.22 after adjustment for baseline score and grade of severity).
PMID:18784099 · one of two readings recorded this
Total WOMAC score at 2 years
no effect
the mean (+/-SD) WOMAC score for the surgery group was 874+/-624, as compared with 897+/-583 for the control group
PMID:18784099 · one of two readings recorded this
radiographic disease progression (JSW loss exceeding 0.48 mm), secondary outcome
no effect
Not recorded as a finding: no matching outcome node for a categorical radiographic-progression/odds-of-progression endpoint; only the continuous joint-space-narrowing node is available
Compared to placebo, the odds of progression for any group were not significant (Table 4).
PMID:18821708 · one of two readings recorded this
radiographic progression (JSW loss exceeding 0.48 mm), secondary outcome
no effect
Compared to placebo, the odds of progression for any group were not significant (Table 4).
PMID:18821708 · one of two readings recorded this
length of contiguous NG2 cDNA
The total contiguous cDNA spans 8,071 nucleotides and contains an open reading frame for 2,325 amino acids
PMID:1906475 · one of two readings recorded this
NG2 core protein open reading frame length
The total contiguous cDNA spans 8,071 nucleotides and contains an open reading frame for 2,325 amino acids
PMID:1906475 · one of two readings recorded this
NG2 cytoplasmic tail length
The predicted protein is an integral membrane protein with a large extracellular domain (2,224 amino acids), a single transmembrane domain (25 amino acids), and a short cytoplasmic tail (76 amino acids)
PMID:1906475 · one of two readings recorded this
NG2 extracellular domain length
The predicted protein is an integral membrane protein with a large extracellular domain (2,224 amino acids), a single transmembrane domain (25 amino acids), and a short cytoplasmic tail (76 amino acids)
PMID:1906475 · one of two readings recorded this
NG2 internal repeat length (four repeats)
Four internal repeats, each consisting of 200 amino acids, are found in the extracellular domain of NG2
PMID:1906475 · one of two readings recorded this
NG2 mRNA size (Northern blot)
These cDNAs hybridize to an mRNA species of 8.9 kbp from rat neural cell lines
PMID:1906475 · one of two readings recorded this
NG2 transmembrane domain length
The predicted protein is an integral membrane protein with a large extracellular domain (2,224 amino acids), a single transmembrane domain (25 amino acids), and a short cytoplasmic tail (76 amino acids)
PMID:1906475 · one of two readings recorded this
any adverse event
no effect, pooled relative risk 0.99 (0.76 to 1.31)
At last, a meta-analysis of 12 trials showed a pooled relative risk of 0.99 (0.76 to 1.31) for any adverse event between chondroitin sulfate and placebo.
PMID:19087296 · both readings recorded this
pain, meta-analytic effect size (20 trials, 3846 patients)
decreases, effect size -0.75 (-0.99 to -0.50), n = 3846
The meta-analysis identified a significant beneficial effect of chondroitin sulfate on pain, with an effect size of -0.75 (-0.99 to -0.50).
PMID:19087296 · one of two readings recorded this
pain, meta-analytic effect size for chondroitin sulfate vs placebo (a cited meta-analysis of 20 trials, 3846 patients)
decreases, effect size -0.75 (-0.99 to -0.50)
Not recorded as a finding: a review that discusses its trials without pooling them
The meta-analysis identified a significant beneficial effect of chondroitin sulfate on pain, with an effect size of -0.75 (-0.99 to -0.50).
PMID:19087296 · one of two readings recorded this
pain (pooled meta-analytic effect size)
decreases
The meta-analysis identified a significant beneficial effect of chondroitin sulfate on pain, with an effect size of -0.75 (-0.99 to -0.50).
PMID:19087296 · one of two readings recorded this
loss in minimum joint space width (medial tibiofemoral compartment)
decreases, p = 0.0001, n = 622
The intent-to-treat analysis demonstrated a significant reduction (P < 0.0001) in minimum JSW loss in the CS group (mean +/- SEM -0.07 +/- 0.03 mm) as compared with the placebo group (-0.31 +/- 0.04 mm)
PMID:19180484 · one of two readings recorded this
number needed to treat for avoiding radiographic progression
decreases
The number of patients needed to treat was 8 (95% confidence interval 5-17)
PMID:19180484 · one of two readings recorded this
pain improvement speed, instrument not stated
decreases
Not recorded as a finding: no named pain instrument and 'faster' is a time-course contrast, not a node's measurement
Pain improved significantly faster in the CS group than in the placebo group (P < 0.01).
PMID:19180484 · one of two readings recorded this
pain improvement
decreases, p = 0.01
Pain improved significantly faster in the CS group than in the placebo group (P < 0.01)
PMID:19180484 · one of two readings recorded this
patients with radiographic progression of at least 0.25 mm (relative risk reduction)
decreases, p = 0.0005, n = 622
28% versus 41% [P < 0.0005]; relative risk reduction 33% [95% confidence interval 16-46%]
PMID:19180484 · one of two readings recorded this
proportion of patients with radiographic progression of at least 0.25 mm in minimum JSW
decreases, 28% vs 41%; relative risk reduction 33% (95% CI 16-46%)
Not recorded as a finding: incident-knee-oa-mjsn-progression node requires a 1 mm threshold; this paper uses 0.25 mm
The percentage of patients with radiographic progression > or =0.25 mm was significantly reduced in the CS group compared with the placebo group (28% versus 41% [P < 0.0005]; relative risk reduction 33% [95% confidence interval 16-46%]).
PMID:19180484 · one of two readings recorded this
safety
no effect
There were no differences in safety between groups
PMID:19180484 · one of two readings recorded this
axon penetration of CSPG-containing regions after spinal cord injury
increases
After spinal cord injury, PTPsigma gene disruption enhanced the ability of axons to penetrate regions containing CSPG
PMID:19833921 · one of two readings recorded this
PTPsigma(-/-) neuron inhibition by CSPG in culture
decreases
In culture, PTPsigma(-/-) neurons show reduced inhibition by CSPG
PMID:19833921 · one of two readings recorded this
Change in Health Utility Index score
no effect, p = 0.37
After 24 months of follow-up, HUI score increases by 0.04 (0.02) in the PL group and by 0.05 (0.02) in the CS group (p=0.37)
PMID:19900070 · one of two readings recorded this
Change in Health Utility Index score
increases, p = 0.03
The mean (SD) HUI scores changes from baseline to 6 months were 0.02 (0.02), and 0.05 (0.01) for the PL and CS groups, respectively (p=0.03)
PMID:19900070 · one of two readings recorded this
Health Utility Index score, baseline
no effect, p = 0.31
At baseline, the mean (SD) HUI scores were 0.59 (0.17), and 0.59 (0.18) for the PL and CS groups, respectively (p=0.31 between the two groups)
PMID:19900070 · one of two readings recorded this
Health Utility Index score derived from WOMAC scores by a formula, with incremental cost-effectiveness ratio
increases
Not recorded as a finding: this platform holds no node for the endpoint
CS treatment increases health utilities in patients with knee OA compared to PL over the first 6 months of treatment.
PMID:19900070 · one of two readings recorded this
Health Utility Index score derived from WOMAC scores, chondroitin 4 and 6 sulphate versus placebo (post hoc analysis of STOPP trial)
increases, HUI change from baseline to 6 months 0.05 CS vs 0.02 PL, p = 0.03
Not recorded as a finding: this platform holds no node for the endpoint
The mean (SD) HUI scores changes from baseline to 6 months were 0.02 (0.02), and 0.05 (0.01) for the PL and CS groups, respectively (p=0.03).
PMID:19900070 · one of two readings recorded this
Incremental cost effectiveness ratio per QALY gained
Using the price bracket of CS in Europe, ICER assessment always resulted in a cost below €30,000 per QALY gained, after 6, 12 and 24 months of treatment
PMID:19900070 · one of two readings recorded this
incidence of psoriatic flares
no effect
The incidence of psoriatic flares did not increase after treatments
PMID:20399899 · one of two readings recorded this
knee pain VAS (change)
decreases, p = 0.01, n = 129
After 3 months of treatment, CS was more effective than PBO, relieving pain VAS (CS -26.9+/-24.8 vs PBO -14.23+/-20.8mm, P<0.01)
PMID:20399899 · one of two readings recorded this
Lequesne index; acetaminophen rescue use; plantar psoriasis improvement
decreases, Lequesne CS -4.8 vs PBO -3.3
Not recorded as a finding: no outcome node for Lequesne index or rescue medication use or plantar psoriasis response
After 3 months of treatment, CS was more effective than PBO, relieving pain VAS (CS -26.9+/-24.8 vs PBO -14.23+/-20.8mm, P<0.01), decreasing the Lequesne index (CS -4.8+/-3.4 vs PBO -3.3+/-3.5, P<0.05) and reducing the number of patients using acetaminophen as rescue medication (CS 43% vs PBO 64%, P<0.05).
PMID:20399899 · one of two readings recorded this
Lequesne index (change)
decreases, p = 0.05, n = 129
decreasing the Lequesne index (CS -4.8+/-3.4 vs PBO -3.3+/-3.5, P<0.05)
PMID:20399899 · one of two readings recorded this
PASI, Overall Lesion Severity Scale, Physician's Global Assessment of Change
no effect, n = 129
Regarding PASI, Overall Lesion Severity Scale and Physician's Global Assessment of Change no statistically significant changes were detected in front of PBO
PMID:20399899 · one of two readings recorded this
patients using acetaminophen as rescue medication
decreases, p = 0.05, n = 129
reducing the number of patients using acetaminophen as rescue medication (CS 43% vs PBO 64%, P<0.05)
PMID:20399899 · one of two readings recorded this
plantar psoriasis improvement, proportion improved
increases, CS 87% vs PBO 27%
Not recorded as a finding: no outcome node for plantar psoriasis response
However, CS improved plantar psoriasis compared to PBO (CS 87% vs PBO 27%, P<0.05).
PMID:20399899 · one of two readings recorded this
plantar psoriasis improvement
decreases, p = 0.05
CS improved plantar psoriasis compared to PBO (CS 87% vs PBO 27%, P<0.05)
PMID:20399899 · one of two readings recorded this
Psoriasis Area and Severity Index (PASI), absolute or percentage change not stated
no effect
Not recorded as a finding: sentence never names the compound and PASI node requires stating absolute versus percentage change, which the abstract does not
Regarding PASI, Overall Lesion Severity Scale and Physician's Global Assessment of Change no statistically significant changes were detected in front of PBO.
PMID:20399899 · one of two readings recorded this
Psoriasis Area and Severity Index (PASI) change at 3 months
no effect
Not recorded as a finding: pasi-score node exists but the only sentence is an agentless null that never names the compound
Regarding PASI, Overall Lesion Severity Scale and Physician's Global Assessment of Change no statistically significant changes were detected in front of PBO.
PMID:20399899 · one of two readings recorded this
7-point Global Response Assessment responders (moderately or markedly improved) at the primary endpoint analysis, week 7
22.6% responders (vehicle control) vs 39.4% responders (active therapy), p = 0.15
Not recorded as a finding: the direction is carried only as a signed number
At the primary endpoint analysis (week 7), 22.6% of the vehicle control group were responders compared with 39.4% of the active therapy group (P = .15).
PMID:20494413 · one of two readings recorded this
Global Response Assessment responders (moderately or markedly improved) at week 7, primary endpoint
22.6% vehicle control group vs 39.4% active therapy (chondroitin sulfate) group responders, p = 0.15
Not recorded as a finding: a direction is stated and the estimate does not support it
At the primary endpoint analysis (week 7), 22.6% of the vehicle control group were responders compared with 39.4% of the active therapy group (P = .15).
PMID:20494413 · one of two readings recorded this
body mass and body length
decreases
At 4 weeks after birth, the body mass and the body length of the null mice were slightly reduced compared with those of the wild-type
PMID:20812917 · one of two readings recorded this
cartilage thickness (percent narrower)
decreases
The cartilage thickness at E18.5 was 25% narrower in CSGalNAcT1-null mice than in wild-type animals
PMID:20812917 · one of two readings recorded this
cartilage thickness (percent thinner)
decreases
After 4 weeks of postnatal development, the cartilage of the null mice was still 15% thinner than that of the wild-type controls
PMID:20812917 · one of two readings recorded this
CS chain length (gel filtration, shorter chains)
decreases
The longest CS chains were preserved in the null mice, but the amount of shorter chains was significantly reduced relative to the amount in wild-type animals
PMID:20812917 · one of two readings recorded this
CS disaccharide composition (non-sulfated disaccharide proportion)
decreases
CS in the null mice was compositionally similar to that in the control mice except for a reduction in the proportion of the non-sulfated disaccharide
PMID:20812917 · one of two readings recorded this
CSGalNAcT1 mRNA level in heterozygous mice (relative to wild-type)
decreases
The protein and mRNA levels in heterozygous mice (CSGalNAcT1+/−) were decreased to 38% and 40% respectively of those in the wild-type controls
PMID:20812917 · one of two readings recorded this
CSGalNAcT1 protein level in heterozygous mice (relative to wild-type)
decreases
The protein and mRNA levels in heterozygous mice (CSGalNAcT1+/−) were decreased to 38% and 40% respectively of those in the wild-type controls
PMID:20812917 · one of two readings recorded this
expression of other CS-synthesis enzymes incl. CSGalNAcT2 (compensation)
no effect
Other enzymes related to CS synthesis, including CSGalNAcT2, a paralogue of CSGalNAcT1, were not up-regulated in the CSGalNAcT1-null mice
PMID:20812917 · one of two readings recorded this
femur length at E18.5 (significance)
decreases, p = 0.00001
The femurs at E18.5 of the null mice are significantly shorter than those of wild-type and heterozygous mice (Student's t test; P<0.00001)
PMID:20812917 · one of two readings recorded this
femur length (percent shorter)
decreases
The null mice had femurs that were 10% shorter than those of wild-type and heterozygous mice on E18.5
PMID:20812917 · one of two readings recorded this
PCNA cell proliferation marker staining in chondrocytes
no effect
Staining for the cell proliferation marker PCNA was similar in chondrocytes of wild-type and null mice (results not shown)
PMID:20812917 · one of two readings recorded this
total CS content in cartilage
decreases, n = 6
total CS content in CSGalNAcT1-null mice was less than half (31.0±3.0 nmol/mg of protein; n=6 of each; Figure 2A) of that in the wild-type controls
PMID:20812917 · one of two readings recorded this
total CS content in cartilage
no effect
CS production in the cartilage of heterozygous mice (64.4±5.3 nmol/mg of protein) was not reduced compared with that of wild-type mice (63.0±4.4 nmol/mg of protein)
PMID:20812917 · one of two readings recorded this
type-II collagen fibre ultrastructure (aggregation)
increases
Type-II collagen fibres were abnormally aggregated in the proliferative and resting layers of the cartilage
PMID:20812917 · one of two readings recorded this
mean number of UTI per patient per year; time to UTI recurrence, intravesical instillation
decreases
Not recorded as a finding: the intervention held more than the compound
Compared with placebo, HA-CS intravesical instillations significantly reduced UTI rate without severe side effects while improving symptoms and QoL over a 12-mo period in patients with recurrent UTI.
PMID:21272992 · one of two readings recorded this
mean time to UTI recurrence
unclear, p = 0.001, n = 57
the mean time to UTI recurrence (52.7±33.4 vs 185.2±78.7 d; p<0.001)
PMID:21272992 · one of two readings recorded this
Pelvic Pain and Urgency/Frequency questionnaire symptom score
modulates, p = 0.004, n = 57
Pelvic Pain and Urgency/Frequency questionnaire symptom score: 14.53±4.32 vs 9.88±6.77; p=0.004
PMID:21272992 · one of two readings recorded this
SF-36 QoL score
increases, p = 0.001, n = 57
SF-36 QoL score: 78.6±6.44 vs 53.1±4.72; p<0.001
PMID:21272992 · one of two readings recorded this
UTI rate per patient per year at 12 months, and mean time to UTI recurrence
decreases, UTI rate -86.6% vs -9.6%; mean difference 77%; 95% CI 72.3-80.8, p = 0.0002, n = 57
Not recorded as a finding: the intervention held more than the compound
The UTI rate per patient per year at the end of the study (12 mo) (mean±SD: -86.6%±47.6 vs -9.6%±24.6; mean difference: 77%; 95% confidence interval, 72.3-80.8; p=0.0002) and the mean time to UTI recurrence (52.7±33.4 vs 185.2±78.7 d; p<0.001) were significantly reduced after treatment with HA-CS compared with placebo.
PMID:21272992 · one of two readings recorded this
UTI rate per patient per year (change)
decreases, p = 0.0002, n = 57
The UTI rate per patient per year at the end of the study (12 mo) (mean±SD: -86.6%±47.6 vs -9.6%±24.6; mean difference: 77%; 95% confidence interval, 72.3-80.8; p=0.0002)
PMID:21272992 · one of two readings recorded this
bone marrow lesion (BML) score by MRI
decreases, lower BML scores in lateral compartment (p=0.035) and lateral femoral condyle (p=0.044) at 12 months
Significantly lower BML scores were found for the CS group at 12 months in the lateral compartment (p=0.035) and the lateral femoral condyle (p=0.044).
PMID:21367761 · one of two readings recorded this
Bone marrow lesion score, lateral compartment (MRI)
decreases, p = 0.035
Significantly lower BML scores were found for the CS group at 12 months in the lateral compartment (p=0.035) and the lateral femoral condyle (p=0.044)
PMID:21367761 · one of two readings recorded this
Bone marrow lesion score, lateral femoral condyle (MRI)
decreases, p = 0.044
Significantly lower BML scores were found for the CS group at 12 months in the lateral compartment (p=0.035) and the lateral femoral condyle (p=0.044)
PMID:21367761 · one of two readings recorded this
cartilage volume loss by MRI (global knee, lateral compartment, tibial plateaus); subchondral bone marrow lesion scores by MRI
less cartilage volume loss in CS group than placebo: global knee p=0.030, lateral compartment p=0.015, tibial plateaus p=0.002, p = 0.03
Not recorded as a finding: a node exists but the paper states a different instrument or population
The CS group showed significantly less cartilage volume loss than the placebo group as early as 6 months for the global knee (p=0.030), lateral compartment (p=0.015) and tibial plateaus (p=0.002), with significance persisting at 12 months.
PMID:21367761 · one of two readings recorded this
cartilage volume loss by MRI (global knee, lateral compartment, tibial plateaus)
decreases, significantly less cartilage volume loss with CS than placebo from 6 months, persisting to 12 months, p = 0.03
Not recorded as a finding: this platform holds no node for the endpoint
The CS group showed significantly less cartilage volume loss than the placebo group as early as 6 months for the global knee (p=0.030), lateral compartment (p=0.015) and tibial plateaus (p=0.002), with significance persisting at 12 months.
PMID:21367761 · both readings recorded this
Cartilage volume loss, global knee (MRI)
decreases, p = 0.03
The CS group showed significantly less cartilage volume loss than the placebo group as early as 6 months for the global knee (p=0.030), lateral compartment (p=0.015) and tibial plateaus (p=0.002), with significance persisting at 12 months
PMID:21367761 · one of two readings recorded this
Cartilage volume loss, lateral compartment (MRI)
decreases, p = 0.015
The CS group showed significantly less cartilage volume loss than the placebo group as early as 6 months for the global knee (p=0.030), lateral compartment (p=0.015) and tibial plateaus (p=0.002), with significance persisting at 12 months
PMID:21367761 · one of two readings recorded this
cartilage volume loss (MRI): global knee, lateral compartment, tibial plateaus
decreases, significantly less loss with CS than placebo from 6 months, persisting to 12 months, p = 0.03
The CS group showed significantly less cartilage volume loss than the placebo group as early as 6 months for the global knee (p=0.030), lateral compartment (p=0.015) and tibial plateaus (p=0.002), with significance persisting at 12 months.
PMID:21367761 · one of two readings recorded this
Cartilage volume loss, tibial plateaus (MRI)
decreases, p = 0.002
The CS group showed significantly less cartilage volume loss than the placebo group as early as 6 months for the global knee (p=0.030), lateral compartment (p=0.015) and tibial plateaus (p=0.002), with significance persisting at 12 months
PMID:21367761 · one of two readings recorded this
disease symptoms (unspecified instrument)
no effect
Disease symptoms were similar between the two groups.
PMID:21367761 · one of two readings recorded this
disease symptoms
no effect
Disease symptoms were similar between the two groups.
PMID:21367761 · one of two readings recorded this
Disease symptoms
no effect
Disease symptoms were similar between the two groups
PMID:21367761 · one of two readings recorded this
subchondral bone marrow lesion (BML) score (MRI): lateral compartment, lateral femoral condyle
decreases, significantly lower BML scores in CS group at 12 months, p = 0.035
Significantly lower BML scores were found for the CS group at 12 months in the lateral compartment (p=0.035) and the lateral femoral condyle (p=0.044).
PMID:21367761 · one of two readings recorded this
subchondral bone marrow lesion scores by MRI, lateral compartment and lateral femoral condyle
decreases, lower BML scores in CS group at 12 months, lateral compartment p=0.035, lateral femoral condyle p=0.044, n = 69
Not recorded as a finding: no outcome node for bone marrow lesion score; also reported at 12 months only, after both arms had received open-label CS
Significantly lower BML scores were found for the CS group at 12 months in the lateral compartment (p=0.035) and the lateral femoral condyle (p=0.044).
PMID:21367761 · one of two readings recorded this
cell-mediated scaffold contraction (normalized diameter)
no effect, p = 0.06
At 1 day all groups maintained a normalized diameter greater than 0.95 with no significant difference between variants (p = 0.06)
PMID:21550653 · one of two readings recorded this
cell-mediated scaffold contraction (normalized diameter)
increases, p = 0.01
for all subsequent time points the isotropic control scaffold showed significantly greater contraction than all anisotropic variants (day 4: p < 0.05; days 7, 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
cell-mediated scaffold contraction (normalized diameter)
increases, p = 0.05
for all subsequent time points the isotropic control scaffold showed significantly greater contraction than all anisotropic variants (day 4: p < 0.05; days 7, 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
cell-mediated scaffold contraction (normalized diameter)
increases, p = 0.01
for all subsequent time points the isotropic control scaffold showed significantly greater contraction than all anisotropic variants (day 4: p < 0.05; days 7, 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
cell-mediated scaffold contraction (normalized diameter)
decreases, p = 0.01
By day 14, the anisotropic scaffold with the largest pores (243 μm) showed significantly reduced contraction compared to the other anisotropic scaffolds as well as the isotropic control (p = 0.01)
PMID:21550653 · one of two readings recorded this
mean pore size (combined planes)
The isotropic scaffold control had an isotropic structure (AR: 1.05 ± 0.03) with a mean pore size (combined transverse and longitudinal planes) of 87 ± 10 μm
PMID:21550653 · one of two readings recorded this
mean pore size (transverse plane)
modulates, p = 0.001
Scaffolds fabricated at freezing temperatures of −10 °C, −40 °C, and −60 °C demonstrated statistically significant differences in pore sizes (p < 0.001): 243 ± 29, 152 ± 25, and 55 ± 18 μm
PMID:21550653 · one of two readings recorded this
mean pore size (transverse plane)
modulates, p = 0.001
Scaffolds fabricated at freezing temperatures of −10 °C, −40 °C, and −60 °C demonstrated statistically significant differences in pore sizes (p < 0.001): 243 ± 29, 152 ± 25, and 55 ± 18 μm
PMID:21550653 · one of two readings recorded this
mean pore size (transverse plane)
modulates, p = 0.001
Scaffolds fabricated at freezing temperatures of −10 °C, −40 °C, and −60 °C demonstrated statistically significant differences in pore sizes (p < 0.001): 243 ± 29, 152 ± 25, and 55 ± 18 μm
PMID:21550653 · one of two readings recorded this
pore aspect ratio (AR)
The isotropic scaffold control had an isotropic structure (AR: 1.05 ± 0.03) with a mean pore size (combined transverse and longitudinal planes) of 87 ± 10 μm
PMID:21550653 · one of two readings recorded this
pore size reduction in bottom section of scaffold
decreases, p = 0.05
the bottom section of the 55 μm scaffold (closest to the freeze-dryer) showed a 35% reduction in pore size (p < 0.05)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity by pore size (243 μm highest)
increases, p = 0.001
a pore size dependent effect was observed on TC metabolic activity within the anisotropic scaffolds, with the largest scaffold (pore size: 243 μm) showing the highest metabolic activity (day 4: p < 0.0001; day 7: p < 0.01; day 14: p < 0.001)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity by pore size (243 μm highest)
increases, p = 0.0001
a pore size dependent effect was observed on TC metabolic activity within the anisotropic scaffolds, with the largest scaffold (pore size: 243 μm) showing the highest metabolic activity (day 4: p < 0.0001; day 7: p < 0.01; day 14: p < 0.001)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity by pore size (243 μm highest)
increases, p = 0.01
a pore size dependent effect was observed on TC metabolic activity within the anisotropic scaffolds, with the largest scaffold (pore size: 243 μm) showing the highest metabolic activity (day 4: p < 0.0001; day 7: p < 0.01; day 14: p < 0.001)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity, IGF-1 100 ng/mL supplementation
increases, p = 0.05
While IGF-1 supplemented scaffolds also displayed significantly (p < 0.05) higher TC metabolic activity compared to the non-supplemented control for each scaffold and at all three time points
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity, IGF-1 50 and 100 ng/mL
increases, p = 0.05
IGF-1 concentrations of 50 and 100 ng/mL also led to a significant increase in TC metabolic activity versus the non-supplemented controls (p < 0.05)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity, IGF-1 500 ng/mL
no effect, p = 0.07
the 500 ng/mL IGF-1 group also showed increased TC metabolic activity compared to control, but the difference was not quite significant (p = 0.07)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity, PDGF-BB 100 ng/mL supplementation
increases, p = 0.05
For all scaffolds and time points, PDGF-BB supplementation significantly (p < 0.05) increased TC metabolic activity compared to non-supplemented controls
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity, PDGF-BB (all three doses)
increases, p = 0.05
All three PDGF-BB groups showed significantly increased TC metabolic activity compared to the non-supplemented control (p < 0.05)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity vs isotropic control
increases, p = 0.0001
the aligned scaffold variants all supported significantly higher TC metabolic activity compared to the isotropic control (day 1: p < 0.0001; days 4, 7: p < 0.001; day 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity vs isotropic control
increases, p = 0.01
the aligned scaffold variants all supported significantly higher TC metabolic activity compared to the isotropic control (day 1: p < 0.0001; days 4, 7: p < 0.001; day 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity vs isotropic control
increases, p = 0.001
the aligned scaffold variants all supported significantly higher TC metabolic activity compared to the isotropic control (day 1: p < 0.0001; days 4, 7: p < 0.001; day 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
tendon cell metabolic activity vs isotropic control
increases, p = 0.001
the aligned scaffold variants all supported significantly higher TC metabolic activity compared to the isotropic control (day 1: p < 0.0001; days 4, 7: p < 0.001; day 14: p < 0.01)
PMID:21550653 · one of two readings recorded this
tendon cell number, 152 μm scaffold with PDGF-BB vs other pore sizes
increases, p = 0.05
At all time points the 152 μm scaffold with PDGF-BB supplementation had significantly higher TC number that the other pore sizes (p < 0.05)
PMID:21550653 · one of two readings recorded this
tendon cell number between IGF-1 groups
no effect, p = 0.49
there were no significant differences in TC number between the IGF-1 experimental groups at day 7 (p = 0.49)
PMID:21550653 · one of two readings recorded this
tendon cell number (DNA) vs isotropic control
increases, p = 0.05
for each remaining time point the aligned scaffolds contained significantly greater numbers of TCs than the isotropic control (p < 0.05)
PMID:21550653 · one of two readings recorded this
tendon cell number, PDGF-BB 100 ng/mL supplementation
increases, p = 0.05
PDGF-BB supplemented scaffolds showed a significant (p < 0.05) increase in TC number at each time point compared to non-supplemented controls
PMID:21550653 · one of two readings recorded this
tendon cell orientation along pore alignment (between −10° and +10°)
increases, p = 0.02
Within anisotropic scaffolds, TCs were significantly (p < 0.02) more likely to be oriented in the direction of scaffold pore alignment and directional solidification (between −10° and +10°)
PMID:21550653 · one of two readings recorded this
tendon cell penetration into scaffold
decreases
TCs in the scaffold with the smallest pore size (55 μm) were observed to be aggregated at the edge of the scaffold with little to no penetration into the scaffold network
PMID:21550653 · one of two readings recorded this
tendon cells attached at day 1 (percent of seeded)
At day 1 between 40 and 55% of the originally seeded TCs remained attached to the scaffold network
PMID:21550653 · one of two readings recorded this
tendon cells recruited, chemokinesis vs chemotaxis condition
no effect, p = 0.93
did not have a significant effect on the number of TCs recruited into the scaffold at 24 h (PDGF-BB 50 ng/mL; p = 0.93; data not shown)
PMID:21550653 · one of two readings recorded this
tendon cells recruited into scaffold, IGF-1 (all three doses)
increases, p = 0.05
All three IGF-1 doses led to significantly higher numbers of recruited TCs within the scaffold after 24 h compared to the control (p < 0.05)
PMID:21550653 · one of two readings recorded this
tendon cells recruited into scaffold, PDGF-BB 100 ng/mL
increases, p = 0.05
with 100 ng/mL supplementation recruiting a significantly greater number of TCs compared to the non-supplemented control and the lower PDGF-BB concentrations (p < 0.05)
PMID:21550653 · one of two readings recorded this
contiguous CS-E binding site on neurotrophin-Trk complex (computational modelling)
unclear
we identify a contiguous CS-E-binding site by computational modeling that suggests a potential mechanism to explain how CS may promote neurotrophin-tyrosine receptor kinase (Trk) complex formation and neurotrophin signaling
PMID:21628576 · one of two readings recorded this
CS assembly of multimeric signaling complexes and modulation of neurotrophin signaling
modulates
Our studies show for the first time that CS is capable of assembling multimeric signaling complexes and modulating neurotrophin signaling pathways
PMID:21628576 · one of two readings recorded this
CS-E interaction with neurotrophins (microarray)
increases
identify previously undescribed interactions between a specific sulfated epitope on chondroitin sulfate, CS-E, and the neurotrophins
PMID:21628576 · one of two readings recorded this
duration of morning stiffness and investigator's global impression of treatment efficacy
decreases
There was a statistically significant between-group difference in favor of CS for the duration of morning stiffness and for the investigator's global impression of treatment efficacy
PMID:21898340 · one of two readings recorded this
grip strength, acetaminophen consumption and safety end points
no effect
Not recorded as a finding: sentence does not name the compound (arm label only) and is a pooled list; grip strength node exists but quote not self-supporting
Changes in grip strength, acetaminophen consumption, and safety end points were not significantly different between the two groups.
PMID:21898340 · one of two readings recorded this
grip strength, acetaminophen consumption and safety end points
no effect
Changes in grip strength, acetaminophen consumption, and safety end points were not significantly different between the two groups
PMID:21898340 · one of two readings recorded this
grip strength, acetaminophen consumption and safety endpoints
no effect
Not recorded as a finding: the only sentence never names the compound and no arm-label definition resolves it; grip strength node exists but quote not self-supporting
Changes in grip strength, acetaminophen consumption, and safety end points were not significantly different between the two groups.
PMID:21898340 · one of two readings recorded this
hand function (FIHOA score)
decreases, p = 0.008, n = 162
Hand function improved significantly more in the CS group than in the placebo group (difference in FIHOA scores -2.14; P = 0.008)
PMID:21898340 · one of two readings recorded this
hand function, Functional Index for Hand OA (FIHOA) 0-30 scale
decreases, difference in FIHOA scores -2.14, p = 0.008
Not recorded as a finding: no outcome node for FIHOA
Hand function improved significantly more in the CS group than in the placebo group (difference in FIHOA scores -2.14; P = 0.008).
PMID:21898340 · both readings recorded this
patient's global assessment of hand pain (VAS 0-100 mm)
decreases, p = 0.016, n = 162
There was a significantly more pronounced decrease in the patient's global assessment of hand pain in the CS group than in the placebo group (difference VAS scores -8.7 mm; P = 0.016)
PMID:21898340 · one of two readings recorded this
Global Response Assessment responders (moderate or marked improvement) at week 11
38.0% chondroitin sulfate group vs 31.3% inactive control group
Not recorded as a finding: a direction is stated and the estimate does not support it
More patients in the chondroitin sulfate group (38.0%) reported moderate or marked improvement (considered responders) compared with the inactive control group (31.3%) at the 11-week endpoint visit.
PMID:22516357 · one of two readings recorded this
Global Response Assessment response (moderate or marked improvement, considered responders) at week 11
38.0% responders (chondroitin sulfate) vs 31.3% responders (inactive control) at week 11
Not recorded as a finding: a direction is stated and the estimate does not support it
More patients in the chondroitin sulfate group (38.0%) reported moderate or marked improvement (considered responders) compared with the inactive control group (31.3%) at the 11-week endpoint visit.
PMID:22516357 · one of two readings recorded this
clinical symptoms (Lequesne index, pain VAS)
decreases
After 48 weeks, symptoms improved in both groups
PMID:22729470 · one of two readings recorded this
correlation between MRI parameter changes and symptoms
no effect
No correlations were evidenced between key MRI parameters changes and symptoms
PMID:22729470 · one of two readings recorded this
other MRI parameters
no effect
No statistically significant differences between groups were observed for the other MRI parameters
PMID:22729470 · one of two readings recorded this
total cartilage volume change (MRI)
increases
The total cartilage volume increased in the Structum® group (+180 mm(3) + SD) which opposed to a loss in the placebo (-46 mm(3) + SD; NS)
PMID:22729470 · one of two readings recorded this
total knee cartilage volume by quantitative MRI after 48 weeks, Structum 500 mg twice daily versus placebo
+180 mm3 Structum vs -46 mm3 placebo; NS
Not recorded as a finding: a direction is stated and the estimate does not support it
The total cartilage volume increased in the Structum® group (+180 mm(3) + SD) which opposed to a loss in the placebo (-46 mm(3) + SD; NS).
PMID:22729470 · one of two readings recorded this
total knee cartilage volume by quantitative MRI
+180 mm3 in the Structum group vs -46 mm3 in placebo (NS)
Not recorded as a finding: a direction is stated and the estimate does not support it
The total cartilage volume increased in the Structum® group (+180 mm(3) + SD) which opposed to a loss in the placebo (-46 mm(3) + SD; NS).
PMID:22729470 · one of two readings recorded this
articular cartilage degradation in knee joints (safranin O / fast green histology)
no effect
showed no articular degradation in any knee joints nor obvious morphologic changes in CSS2−/− mice
PMID:22952769 · one of two readings recorded this
C0S disaccharide fraction of cartilage CS
no effect
representing 2.8%, 96.1%, 1.1%, 0% and 0% for WT cartilage, and 2.8%, 96.3%, 0.9%, 0% and 0% for CSS2−/− cartilage
PMID:22952769 · one of two readings recorded this
C4S disaccharide fraction of cartilage CS
no effect
representing 2.8%, 96.1%, 1.1%, 0% and 0% for WT cartilage, and 2.8%, 96.3%, 0.9%, 0% and 0% for CSS2−/− cartilage
PMID:22952769 · one of two readings recorded this
C6S disaccharide fraction of cartilage CS
no effect
representing 2.8%, 96.1%, 1.1%, 0% and 0% for WT cartilage, and 2.8%, 96.3%, 0.9%, 0% and 0% for CSS2−/− cartilage
PMID:22952769 · one of two readings recorded this
Sources cited
6 papers
- Subject
- chondroitin sulfate
- Findings
- 6
- Papers
- 6
The therapeutic potential of chondroitin sulfate in Aspergillus fumigatus keratitis.record2022PMID:355040581 finding
Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.record2016PMID:267140441 finding
Chondroitin for osteoarthritis.record2015PMID:256298041 finding
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.record2012PMID:224698501 finding
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration.record2010PMID:203998951 finding
The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate .record2008PMID:188267511 finding
Other names
4 names
Resolves to: chondroitin sulfate
- Also called
- chondroitin polysulfatechondroitin sulfateschondroitin sulfuric acidchondroitin sulphate